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The prevalence of neurodevelopmental disorders (NDs), including autism spectrum disorder, attention‑deficit/hyperactivity 
disorder, tic disorder, obsessive‑compulsive disorder, and emotional disturbances, has increased notably in the past few decades. 
To date, debate continues as to the origins of NDs. Increases in widespread exposure to and bioaccumulation of chemical 
neurotoxicants have paralleled the upsurge in NDs, and are suggested to be causal agents for NDs. One consistent aspect of NDs 
is the male preponderance. This review considers the issue of male preponderance by reviewing the gender‑specific neurotoxic 
effects of recognized neurotoxicant chemicals to assess their possible etiology in NDs. This investigation consisted of a systematic 
literature review of original studies published from 1970–2016 on suspected neurotoxicants, to examine whether they have 
a disproportionate adverse effect based on gender. Based on that review, the neurotoxicants exhibiting consistent gender‑specific 
effects, with exposed males being more affected (than similarly exposed females), were: lead, Thimerosal/ethylmercury, 
some organochlorine pesticides (e.g., dieldrin, endosulfan, and heptachlor), and air pollution. The next group identified were 
neurotoxicants exhibiting gender‑specific neurotoxic effects, with males being somewhat (but not consistently) more affected than 
females: mercury vapor, polychlorinated biphenyls (PCBs), and organophosphate pesticides. Finally, there was a group of studies 
in which the neurotoxicants exhibited apparent gender‑related neurotoxic effects but failed to show whether exposed males 
were consistently more affected than females: inorganic mercury salts, methylmercury species, and certain endocrine disruptors 
(e.g., phthalates and BPA). The overall conclusion from the studies reviewed was that the brain in males is more vulnerable to 
many toxic exposures than it is in females. Evidence suggests that the reasons for the male brain being more vulnerable include: 
(1) greater glutathione availability in females; (2) greater sulfate‑based detoxification capacity in females; (3) potentiating effects 
of co‑exposure to neurotoxicants and testosterone; (4) greater neuroinflammatory response in males; (5) reduced vulnerability 
to oxidative stress in females; and (6) neuroprotective effects of female hormones (estrogen and progesterone), especially in the 
reduction of inflammation and oxidative stress. 
Key words: neurodevelopmental disorders; mercury; metals; autism; neurotoxicants; autism spectrum disorder, attention deficit 
hyperactivity disorder, tic disorder, obsessive‑compulsive disorder, and emotional disturbances
INTRODUCTION
The incidence and prevalence of neurodevelop‑
mental disorders has increased notably in the past few 
decades. In the United States of America (US) in 1976, 
the ratio of children diagnosed with learning disabil‑
ity to the total population of children was 1 in 30; in 
2013, that ratio was 1 in 6 (Boyle at al., 2011; Campbell, 
2015). In 1988, that ratio for those diagnosed with an 
autism spectrum disorder (ASD) was 1 in 1000 children; 
in 2013, that ratio was 1 in 45 children (Bryson et al., 
1988; Sugiyama and Abe, 1989; Zablotsky et al., 2015). 
For children diagnosed with an attention deficit hyper‑
activity disorder (ADHD), that ratio was 1 in 18 children 
in 1996; in 2012, that ratio was 1 in 8 children – an in‑
crease of about 75 percent (Child Trends, 2014). Tic dis‑
order was once considered to be rare, but, by 2012, up 
to 46% of school‑aged children experienced tics during 
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their lifetime, making tic disorder the most common 
movement disorder (Cubo, 2012). Also, obsessive‑com‑
pulsive disorder (OCD), once thought to be rare, now 
affects one in 50–100 children (Beyond OCD, 2015). The 
number of children considered emotionally disturbed 
in 1980 was 1 in 50 children (US Department of Educa‑
tion, 1980); in 2004, that ratio had increased to 1 in 11 
children (Wagner et al., 2005) (Table I). 
Based on a large study conducted in 2011 by the 
US Centers for Disease Control and Prevention (CDC), 
roughly one child in six in the US is now diagnosed with 
a neurodevelopmental disorder (Boyle et al. 2011). This 
represents a dramatic increase in the last few decades. 
Those increases in neurodevelopmental disorders have, 
in turn, led to today’s crises in our educational, medi‑
cal, parental, and custodial care systems. Many of those 
children are teens who are now aging out of the educa‑
tion systems (Autism Speaks 2012). A greater care crisis 
will occur when their aging parents become unable to 
care for their children. 
Whether these reported increases reflect true in‑
creases in the rates of neurodevelopmental disorders 
has been questioned. The non‑etiological factors asso‑
ciated with an increased rate of neurodevelopmental 
disorders may include changes in diagnostic criteria, 
the inclusion of milder cases, and earlier age at diag‑
nosis. However, several studies have specifically exam‑
ined this issue and determined that these parameters, 
at most, can explain only a portion of the increase in 
neurodevelopmental disorders.
For instance, in a study of increasing ASD rates in 
California from 1990 to 2006, Hertz‑Picciotto and Del‑
wiche (2009) reported that the California ASD rate in‑
creased by 600%. They explained 200% of that 600% in‑
crease: 120% was from changes in diagnostic criteria (a 
2.2‑fold increase); 56% was from the inclusion of milder 
cases (a 1.56‑fold increase), and 24% was from the earli‑
er age at diagnosis (a 1.24‑fold increase). They conclud‑
ed that, given the uncertainties in their analyses, their 
explanations only accounted for between 200 and 400% 
of the 600% increase. They reported that there were 
other possible, but as yet unquantified, artifacts in the 
dataset that their study used. Based on the absence of 
values for those artifacts, they declined to claim that 
the reported increase represents a true increase. How‑
ever, the reported residual (of 200–400%) would be hard 
to explain without true etiological factors.
Similarly, a study by King and Bearman (2011), us‑
ing a large and representative dataset that spanned 
the California birth cohorts from 1992 through 2000, 
examined individual and community resources associ‑
ated with the likelihood of an ASD diagnosis over time. 
Their study objective was to identify key social factors 
that have contributed to the numerical increase in ASD 
prevalence. However, they found that their study was 
unable to explain about half of the observed time‑re‑
lated increases.
For decades, the USDepartment of Education has 
regularly provided independent reports on the num‑
bers of children identified as having developmental 
disabilities in the US school system; and those reports 
have consistently shown nation‑wide average increas‑
es in neurodevelopmental disorders (U.S. Department 
of Education 1980, 2016). For example, the number of 
children and youths 3–21 years of age who received 
special education services increased from 4.7 million 
(11 percent of total public school enrollment) from 
school years 1990–91 through 2004–05 to 6.7 million 
(14 percent of total public school enrollment) in the 
last reported school year – a 27% relative net increase 
Table I. The prevalence (male/female ratio) and average annual increases in neurodevelopmental disorders in the US for males
Neurodevelopmental disorder Male / female ratio Incidence Rate for Diagnosis(in year)
Average annual  
rate increase
Learning disabled 2 to 1 1 in 30 (1976)
1 in 6  
(2013) 4.45%
Autism spectrum disorder (ASD) 4 to 1 1 in 1000  (1988)
1 in 45  
(2013) 13.2%
Attention deficit hyperactivity disorder (ADHD) 5 to 1 1 in 18  (1996)
1 in 8  
(2012) 5.2%
Tic disorder 3–4 to 1 rare* (1980)
1 in 2 
(2012) extremely high
Obsessive‑compulsive disorder (childhood) 3 to 2 rare* (1980)
1 in 100 to 50  
(2015) extremely high
Emotionally disturbed 3 to 1 1 in 50  (1980)
1 in 11  
(2004) 6.5%
Neurodevelopmental disorders in general — 1 in 6 (2011) —
* “rare” is estimated as less than (<) 1 in 10,000.
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during the 14 year period (National Center for Educa‑
tion Statistics 2016). Those findings were reflected in 
a growing need for and an increase in the California 
financial support level for special‑accommodation ‑ 
programs which many high‑functioning autistics (who 
are allegedly driving up the reported ASD rates) would 
not need. The “special‑ed” stigma may offset the “spe‑
cial‑ed” benefits such that the Department of Educa‑
tion data is likely to represent a true increase in neuro‑
developmental disorders.
A study by Geier et al. (2015) examined prospective 
longitudinal medical records to evaluate whether diag‑
nostic substitution from other diagnoses such as mental 
retardation (MR) and/or cerebral palsy (CP) to an ASD 
diagnosis was the driving factor behind increased ASD 
diagnoses in the US. The results observed were inconsis‑
tent with diagnostic substitution as a significant driving 
force in the increase in ASD diagnosis, and, in fact, re‑
vealed significant important clinical differences in the 
features associated in those with an ASD diagnosis in 
comparison to those with a CP or MR diagnosis. Specif‑
ically, it was observed that those with an ASD diagnosis 
had a significant increase in male/female ratio, delayed 
mean age of initial diagnosis, and a lack of significant 
problems at birth in comparison to those with an MR or 
CP diagnosis. By contrast, those with an MR or CP diag‑
nosis in comparison to those with an ASD diagnosis had 
a roughly equal male/female ratio, early mean age of ini‑
tial diagnosis, and significant problems at birth.
Regardless of the explanations or lack thereof, to‑
day’s reported overall rate (roughly one child in six is 
being diagnosed with a neurodevelopmental disorder) 
is a crisis that deserves scrutiny.
One aspect that many neurodevelopmental disor‑
ders have in common is male preponderance. In those 
diagnosed with an ASD, today’s male to female ratio is 
about 4 to 1 (Zablotsky et al. 2015). In those having an 
ADHD diagnosis, today’s male to female ratio is roughly 
5 to 1 (Joelsson et al. 2016). For learning delay, that ratio 
is roughly two males to one female. For developmental 
delay, it is also about two males to one female (Liao et 
al. 2015). For tic disorder, that ratio is less certain — 
roughly 3–4 males to one female (Cubo 2012). Emotion‑
al disturbances reflect a similar approximate three to 
one ratio (Wagner et al. 2005). For OCD, although it lev‑
els out in adults, the ratio in childhood is about three 
males to two females (Hanna 1995; Beyond OCD 2015).
In general, many researchers have not recognized 
the importance of finding the most probable causal fac‑
tors for male preponderance in neurodevelopmental 
disorders. When the issue of etiology is addressed, the 
federal and state governmental and the medical‑phar‑
maceutical industry researchers often cite “genetics” 
as the underlying cause for neurodevelopmental dis‑
orders. However, that reason is improbable because 
genetically‑based disorders typically show consistent 
levels or slow growth rates across generations, not dra‑
matic generational increases. Further, the potential for 
sex‑related genetic alterations to explain the observed 
male/female ratio is not supported by the perceived 
inheritance pattern. Finally, in those families with one 
or more children diagnosed with an ASD (the neuro‑
developmental disorder which has shown the greatest 
increase (Boyle et al. 2011) including identical twins, 
genetic investigations have not identified consistent 
genetic changes. Instead, chromosomal microarray 
testing has shown that about 80% of ASD children have 
a normal genome (Shen et al. 2010; Geier et al. 2016a). 
The remaining 20% who have an abnormal genome 
have shown little to no commonality in their genetic 
abnormalities (Shen et al. 2010, Geier et al. 2016, Stess‑
man et al. 2017, Yuen et al. 2017).
Instead, a genetic susceptibility to the risk of de‑
veloping a neurodevelopmental disorder diagnosis is 
suggested, in part, because some of these disorders 
show a higher occurrence rate among siblings (Schen‑
del et al. 2014). Genetic susceptiliblity among families 
to environmentally caused diseases (e.g., acrodynia 
[also called “Pink disease”]) have been described previ‑
ously (Bjørklund 1995, Dally 1997). Specifically, the the 
main cause of Pink disease was children’s exposure to 
inorganic‑mercury‑containing compounds, particular‑
ly teething powders (marketed mainly in the US, the 
United Kindom (UK) and other English‑speaking coun‑
tries that were former UK colonies). Those teething 
powders, which were the main cause of the childhood 
Pink disease cases, contained high levels of mercurous 
chloride (Hg2Cl2), were rubbed on children’s gums to 
lessen their teething pain (Bjørklund 1995, Dally 1997).
Also, as mentioned previously, if genes were a major 
causal factor for neurodevelopmental disorders, it would 
most probably require involvement of sex‑related genes 
on the X chromosome. As a result of X chromosome in‑
volvement, female affected children would have to have 
affected fathers. However, this pattern is not found in 
neurodevelopmental disorders. Thus, the male prepon‑
derances observed indicate that neurodevelopmental 
disorders have environmental causes rather than specif‑
ic genetic abnormalities acting in isolation.
The developing male has long been considered more 
fragile than the developing female (Kraemer 2000). 
In many instances, recent research has reported that 
males are more vulnerable to environmental toxicants 
than females. As discussed in Section 3 below, multi‑
ple studies examining the effects of neurotoxicants on 
neurodevelopmental disorders have found gender‑de‑
pendent neurotoxicity, with males often being signifi‑
cantly more vulnerable than females (Kishi et al. 2013, 
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Allen et al. 2014a, b). Thus, male preponderance has of‑
ten been reported in research studying environmental 
toxicants regardless of whether human cohorts, animal 
models, or tissue culture studies were examined.
In regard to male susceptibility in those diagnosed 
with an ASD, Schaafsma and Paff (2014) described 
many genetic, epigenetic, hormonal, and environmen‑
tal mechanisms that might explain the observed male 
preponderance in ASD, including early exposure to an‑
drogenic hormones and early maternal immune activa‑
tion. Robinson et al. (2013) analyzed two separate, large 
studies of twins and found that the females in those 
studies were more protected from autistic impairments 
relative to the males, indicating that females may re‑
quire larger etiologic loads than males to manifest the 
autistic phenotype. Jacquemont et al. (2014) found that 
females with an ASD diagnosis have a higher muta‑
tional burden, meaning that it takes more mutations 
Table II. The results of the current examination of gender‑specific neurotoxic effects of the neurotoxicants suspected of playing a role in the increase in 
neurodevelopmental disorders
Developmental 
neurotoxicants  
documented in  
human epidemiology 
studies
Grandjean 
and Landrigan 
2006 (formal 
list of 5)
Landrigan 
et al. 2012 
(informal list 
of 13)
Workshop 
described by 
Landrigan 
et al. 2012 
(formal list 
of 10)
Grandjean 
and Landrigan 
2014 (formal 
list of 11)
Project  
TENDR 
Sealey et al. 
2016
Score assigned 
by current 
review
Lead (Pb) X X X X X X 1
Methylmercury (Me‑Hg‑) X X X X X X 3
Polychlorinated biphenyls X X X X X 2
Arsenic (As) X X X X 5
Toluene or other solvents X X X —
Organophosphate 
pesticides (e.g., chlorpyrifos) X X X X X 2
Organochlorine pesticides X X X 1
Endocrine disruptors  
(e.g., phthalates) X X X 3
Automotive exhaust X X 1
Polycyclic aromatic 
hydrocarbons (PAHs) 
or combustion‑related 
air pollutants
X X X X 5
Bisphenol A (BPA) X 3
Polybrominated  
diphenyl ethers  
(PBDE flame retardants)
X X X X 6
Perfluorinated compounds X X 5
Manganese X X —
Fluoride X —
Dichlorodiphenyl‑ 
trichloroethane (DDT) X —
Tetrachloroethylene X —
Glyphosate X 5
Aluminum adjuvants X 5
Fragrances X —
Thimerosal / Other 
ethyl‑Hg‑based compounds 1
1 = Consistent gender‑specific neurotoxic effects with males more affected; 2 = Gender‑specific neurotoxic effects, with males being somewhat more affected, but not 
consistently; 3 = Gender‑specific neurotoxic effects, but it is not clear whether males or females are more affected; 4 = Gender‑specific neurotoxic effects, with females being 
more affected; 5 = Insufficient research on gender‑specific neurotoxic effects; and 6 = No gender‑specific neurotoxic effects reported.
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to trigger an ASD diagnosis in females than it does for 
males, indicating that females have greater resistance 
to the etiologies of an ASD diagnosis than males.
Moreover, the rise in the incidence and prevalence 
of neurodevelopmental disorders has paralleled the 
increase in the widespread exposure to and the bio‑
accumulation of chemical neurotoxicants (Genuis and 
Kelln 2015). Various environmental neurotoxicants or 
xenobiotics have been suggested as causal agents in 
neurodevelopmental disorders (Table II). For example, 
in a widely‑read 2006 study, Grandjean and Landrigan 
identified five industrial chemicals as neurotoxicants: 
lead, methylmercury, polychlorinated biphenyls, arse‑
nic, and toluene. Grandjean and Landrigan et al. (2014) 
in afollow‑up study stated that neurodevelopmental 
disabilities affect over 10% of children born in the US 
each year. Additionally, they listed the top ten envi‑
ronmental compounds suspected of triggering neu‑
rodevelopmental disorders in the affected children: 
lead, methylmercury, polychlorinated biphenyls, or‑
ganophosphate pesticides, organochlorine pesticides, 
endocrine disruptors such as phthalates, automotive 
exhaust, polycyclic aromatic hydrocarbons, polybromi‑
nated diphenyl ethers (PBDEs; brominated flame retar‑
dants), and perfluorinated compounds. Grandjean and 
Landrigan (2014) postulated that these toxic chemicals 
may be responsible for the increase in some neurode‑
velopmental disorders in the past few decades. Overall, 
this theory seems biologically plausible since we are 
living in an increasingly toxic world, and fetuses, in‑
fants, and children are the most vulnerable (Schettler 
2001, Laks 2009, Grandjean and Landrigan, 2014). 
A recent consensus statement by Project TENDR: 
Targeting Environmental Neuro‑Developmental Risks, 
a collaboration of health professionals and children’s 
advocates, also provided examples of toxic chemicals 
that can contribute to learning, behavioral, or intel‑
lectual impairment, as well as to specific neurodevel‑
opmental disorders, such as ADHD and ASD (Bennett 
et al. 2016). Like the list provided by Grandjean and 
Landrigan (2014), their list included organophosphate 
pesticides; PBDE flame retardants;; lead; mercury; and 
polychlorinated biphenyls; combustion‑related air pol‑
lutants, which include polycyclic aromatic hydrocar‑
bons, nitrogen dioxide and particulate matter (Bennett 
et al. 2016).
Sealey et al. (2016) also presented a list of neuro‑
toxicants suspected to play a role in the increase in 
neurodevelopmental disorders. That list added two 
more neurotoxicants in addition to those previously 
mentioned: glyphosate (a chemical used as the “active” 
ingredient in the herbicide Roundup) and aluminum 
adjuvants (annealed polymeric hydroxyaluminum III 
“salts” usually used in vaccines to “indiscriminately ac‑
tivate” the immune systems in the recipients of certain 
vaccines) (Nevison 2014; Sealey at al. 2016). 
In this systematic review, we considered male pre‑
ponderance as an important feature to help elucidate 
potential environmental etiological risk factors relat‑
ed to neurodevelopmental disorders. We analyzed the 
gender‑specific neurotoxic effects of specific neurotoxi‑
cants to assess their role in and the level of contribution 
to neurodevelopmental disorders. Thus, on the premise 
that male preponderance is an important clue to the 
etiology of neurodevelopmental disorders, this inves‑
tigation examined a list of known neurodevelopmental 
toxicants to evaluate the evidence regarding their gen‑
der‑dependent neurotoxicity. This critical review also 
rated the magnitude of gender‑specific effects of the 
neurotoxicants evaluated based on available research. 
Finally, possible biological mechanisms that may explain 
the heightened vulnerabilities of the male brain in com‑
parison to the female brain were examined.
Although two of the reviewed listings of suspect‑
ed causal agents only mentioned the organic mercu‑
ry compound, “methylmercury”, this investigation 
reviewed “mercury species”, a broader category that 
includes methylmercury. Also, even though one of the 
preceding lists of neurotoxicants only included “auto‑
motive exhaust”, this review evaluated “air pollution”, 
a broader category that includes “automotive exhaust”, 
because, in some instances, air pollution includes air‑
borne toxic metal species (both particulate [e.g., alu‑
minum and lead oxides] and gaseous [e.g., elemental 
mercury vapor and nickel tetracarbonyl]). 
METHODS
This investigation comprised a systematic literature 
search of original studies on these suspected neurotoxi‑
cants to examine whether they have a disproportionate 
adverse effect based on gender. The literature search 
from 1970 to August 2016 included published original 
research from PubMed and Google Scholar. In addi‑
tion, the references cited in the identified publications 
were searched to find additional studies. Search terms 
included: neurotoxin, neurotoxicant, toxin, toxicant, 
gender, gender specific, gender bias, sex, sex bias, sex 
selective, gender selective, gender effects, sex effects, 
boys more affected, girls more affected, boys, girls, 
lead, Pb, methylmercury, mercury, mercury vapor, Hg, 
Thimerosal, metals, methyl‑mercury, ethyl‑mercu‑
ry, inorganic‑Hg, mercury chloride, polychlorinated 
biphenyls, organophosphate pesticides, glyphosate, 
Round‑up, organochlorine pesticides, pyrethrins, en‑
docrine disruptors such as phthalates, automotive ex‑
haust, air pollution, particulates, polycyclic aromatic 
1_1156_Kern_v3.indd   273 27/12/17   23:58
274 JK. Kern et al. Acta Neurobiol Exp 2017, 77: 269–296
hydrocarbons, polybrominated diphenyl ethers (bro‑
minated flame retardants), perfluorinated compounds, 
and aluminum adjuvant.
The neurotoxicants were then rated on the extent 
and consistency of gender‑specific neurotoxic effects 
based on the available research, using the following 
scoring system: 
Scoring system
• Score 1 = Consistent gender‑specific neurotoxic ef‑
fects with males more affected;
• Score 2 = Gender‑specific neurotoxic effects, with 
males being somewhat more affected, but not con‑
sistently; 
• Score 3 = Gender‑specific neurotoxic effects, but it 
is not clear whether males or females are more af‑
fected;
• Score 4 = Gender‑specific neurotoxic effects, with 
females being more affected; 
• Score 5 = Insufficient research on gender‑specific 
neurotoxic effects; and
• Score 6 = No gender‑specific neurotoxic effects re‑
ported.
EXAMINATION OF SUSPECTED
NEUROTOXICANTS
Lead (Pb)
Low‑level Lead (Pb from Latin plumbium) exposure 
has negative behavioral and cognitive consequences in 
humans and animals. Even brief Pb exposure during de‑
velopment produces behavioral changes that last well 
beyond the exposure period (Stewart et al. 1998), and 
neurobehavioral deficits from early developmental ex‑
posure to Pb can extend into adulthood (Winneke et al. 
1996). A decrease in the Intelligence Quotient (IQ) score 
of those exposed is typically reported. A Meta‑analy‑
sis of studies in Pb‑exposed children have found that 
a typical doubling of blood Pb levels from 100 to 200 
micrograms/l is associated with an average IQ‑loss of 
1‑3 points (Winneke et al. 1996).
Several studies suggest that Pb exposure affects boys 
more than girls (Llop et al. 2013). For example, Khanna 
et al. (2015) found behavioral evidence that boys experi‑
ence the negative cognitive effects of Pb more than girls. 
In that study, the investigators tested executive func‑
tion and reading readiness skills in 40 young children, 
3–6 years of age (23 children with elevated blood Pb lev‑
els, 17 children without elevated blood Pb levels). Ele‑
vated blood levels of Pb adversely affected male execu‑
tive function performance much more than it decreased 
female executive function performance. Males with el‑
evated blood Pb levels also showed deficits in reading 
readiness compared to males with normal lead levels. 
However, reading readiness scores for females were not 
adversely affected by their observed blood Pb levels.
Using magnetic resonance imaging (MRI), Cecil et 
al. (2008) reported finding, for the 157 subjects evalu‑
ated, that significant decreases in brain volume were 
associated with elevation in their childhood blood Pb 
concentrations. The areas of Pb‑associated losses in 
gray‑matter volume were much larger and more signif‑
icant in the men than the women.
In a follow‑up study of that same cohort of 
157 adults, these researchers (Brubaker et al. 2010) ex‑
amined associations between adult gray matter volume 
loss measured using high resolution volumetric MRI 
and the yearly mean blood Pb levels reported when 
the individuals in the cohort were 1 to 6 years of age. 
When the researchers looked at the data by gender, 
they found that males exposed to Pb during childhood 
and adolescence showed significantly more gray mat‑
ter volume loss in adulthood than the adult females ex‑
posed to Pb when they were young (Khanna et al. 2015, 
Brubaker et al. 2010).
Studying a cohort of 457 three‑year‑old children, 
Jedrychowski et al. (2009) reported on the gender‑spe‑
cific differences in the neurodevelopmental effects of 
prenatal exposure to very‑low‑Pb levels. They mea‑
sured accumulated Pb dose in infants over the pregnan‑
cy period using cord blood lead level (BLL). They used 
the Bayley Mental Development Index (MDI) to assess 
cognitive deficits. Their study results suggested that 
there might be no threshold below which Pb is not tox‑
ic in children and that the 3‑year old boys were more 
susceptible to prenatal very‑low‑Pb exposure than the 
girls in the study.
Several other studies find greater adverse neurocog‑
nitive outcomes in Pb‑exposed males than Pb‑exposed 
females. Froehlich et al. (2007) found that adverse ef‑
fects of Pb on planning and rule‑learning and reversal 
were seen primarily in boys. As early as 1987, a study 
found that the inverse relationship between increasing 
Pb exposure and decreasing IQ scores was much more 
pronounced in boys (Pocock et al. 1987). Ris et al. (2004) 
reported that, for males, increased Pb exposure led to 
increased deficits in both Attention and Visuocon‑
struction (ability to organize and manually manipulate 
spatial information to make a design).
However, one study by Sioen et al. (2013) found 
similar effects in girls and boys exposed to Pb. They 
examined the association between prenatal exposure 
to Pb and other toxic chemicals and behavioral prob‑
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lems in 7–8‑year‑old children. When the children were 
7–8 years of age, 270 of their mothers completed the 
Strengths and Difficulties Questionnaire assessing their 
children’s behavioral health. They found that doubling 
the prenatal Pb exposure (cord blood lead levels) was 
associated with a 3.4 times higher risk for hyperactivi‑
ty in both boys and girls.
In conclusion, the preceding studies clearly support 
assigning Pb a Rating Score of 1, showing consistent 
gender‑specific neurotoxic effects with males more 
affected except for hyperactivity, in which both sexes 
were equally adversely affected. 
Mercury (Hg)
Mercury (Hg) toxicity can be complex and nonlinear 
(Berlin et al. 2015). Its molecular mechanism of toxici‑
ty is unusually broad. Since it binds sulfhydryls, which 
are ubiquitously found in the proteins and peptides dis‑
tributed throughout the body, its toxic effects can affect 
any organ system (Berlin et al. 2015). Many studies have 
shown that Hg is a developmental neurotoxicant in both 
humans and animals. Some studies suggest that devel‑
oping males are more sensitive to Hg exposure than de‑
veloping females (Khan et al. 2012; Woods et al 2014). 
However, upon further investigation, the magnitude 
of the gender effects appear to vary somewhat accord‑
ing to the speciation of the Hg, e.g., elemental mercury 
vapor (Hg0); inorganic mercury salts (mostly Hg2+ [e.g., 
HgCl2] and a few Hg1+ [e.g., Hg2Cl2 {Calomel}]); methyl‑
mercury‑based compounds (principally methylmercury 
species [H3C–Hg–X, where X is chloride {Cl} or hydrox‑
ide {OH}] and where methylmercury may also be repre‑
sented as Me‑Hg—]; or ethylmercury‑based compounds 
or Et‑Hg— (mainly sodium [Na1+] Et‑Hg–thiosalicylate 
[H3C–(H2C)–Hg–thiosalicylate1–]). The toxicokinetics 
of Hg vary depending on the form of Hg. This section 
will examine elemental mercury vapor (Hg0); inorganic 
mercury salts (Hg2+ and Hg1+); methylmercury chloride 
(H3C–Hg–Cl [Me‑Hg‑Cl]) and methylmercury hydroxide 
[Me‑Hg‑OH]); and the sodium salt of ethylmercury thio‑
salicylic acid ([Na+ H3C–(H2C)–Hg–thiosalicylate– or Na+ 
Et–Hg–thiosalicylate–], which is known by various trade‑
names including, but not limited to, Thimerosal, Thio‑
mersal, Timerosal, Tiomersal, and Merthiolate). 
Elemental Mercury Vapor (Hg0)
Elemental mercury vapor (Hg0), such as that which 
is released from dental amalgams, which are roughly 
50: 50 mixtures of elemental Hg and elemental silver 
(Ag) containing minor amounts of other metals (e.g., 
Copper [Cu]) is uncharged and is thus lipophilic. Hg0 is 
rapidly distributed throughout the body, passing easily 
through cell membranes, and is then oxidized into the 
divalently charged form of mercury (Hg2+), which can 
be trapped inside cells (Berlin et al. 2015).
The Casa Pia Clinical Trial of Dental Amalgams in 
Children provided valuable human epidemiological ev‑
idence for the hypothesis that boys tend to retain Hg 
more than girls. Woods et al. (2007) found that mean 
urinary Hg excretion for boys and girls were similar at 
baseline. However, at about two years after amalgam 
placement, urinary Hg excretion declined for both gen‑
ders. The decrease in urinary Hg excretion was much 
larger for the boys than for the girls. This finding sug‑
gests that Hg toxicity is nonlinear and that chronic Hg 
exposure may impair excretion and increase retention. 
Based on the preceding findings, the study’s boys re‑
tained and accumulated significantly higher levels of 
Hg than the study’s girls over the course of comparable 
Hg exposures from Hg‑amalgam dental fillings (Woods 
et al. 2007).
Furthermore, a detailed reanalysis of the Casa Pia 
data, which controlled for certain genetic variants, 
provided remarkable human epidemiological evidence 
that boys with at least one of a dozen common genetic 
variants experienced greater adverse effects in many 
different neurobehavioral outcomes than did the girls 
with the same genetic variants and similar Hg expo‑
sures. Specifically, Woods et al. (2014) investigated the 
effects on susceptibility to Hg toxicity of 27 common 
variants of 13 genes and found that boys with at least 
1 of 12 key variants were significantly affected across 
a broad range of neurobehavioral outcomes, where‑
as girls were much less affected. Their report focused 
on the role of common genetic variants in modifying 
susceptibility to Hg toxicity. However, given that the 
susceptibility genes are numerous and common, the 
alarming subtext of the report is that children, boys in 
particular, get neurobehavioral toxicity from routine 
exposures to Hg, ostensibly from Hg‑amalgam dental 
fillings, which have hitherto been presumed safe. The 
authors noted that their exposure metric, urinary Hg 
levels, may include other Hg sources besides amal‑
gam; however, an earlier study by the same team found 
that urinary Hg levels were correlated with amalgam 
(Woods et al. 2007), and another study found that expo‑
sure to fish Hg in this cohort was insignificant (Evens 
et al. 2001); therefore, it is reasonable to conclude that 
the neurobehavioral impairments are correlated with 
amalgam exposure. For the boys with the variant(s), 
significant dose‑dependent impairments were found in 
most of the 23 neurobehavioral tests administered, and 
the domains most affected were attention, learning and 
memory, visual spatial acuity, and motor function. The 
remaining domain, executive function, was less affect‑
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ed. On the other hand, among the girls evaluated with 
the same genetic variants, modification of the effects 
of Hg on neurobehavioral functions was substantially 
more limited. This study is remarkable not only for its 
indication of both significant adverse effects and gen‑
der differences in susceptible children from routine ex‑
posures, but also because it was a more detailed analy‑
sis of the Casa Pia Clinical Trial of Dental Amalgams in 
Children. The original (2006) results, which found no 
significant difference in the group‑average neurobe‑
havioral outcomes between the Hg‑amalgam group and 
the non‑amalgam group, were widely cited as evidence 
for the safety of Hg‑amalgam fillings, which, in retro‑
spect, appears naive (Homme et al. 2014).
In contrast to this compelling human evidence that 
Hg exposure affects boys significantly more than girls 
in terms of both Hg retention and the resulting neu‑
robehavioral impairments, the findings from two ro‑
dent studies by Yoshida et al. (2005, 2011) suggest that 
female rodents with a certain genetic varient may be 
more susceptible. In the most recent study, the inves‑
tigators found that brain concentrations of Hg were 
significantly higher and total locomotor activity was 
lower in the metallothionein‑null, Hg0‑vapor‑exposed 
female mice than in their male counterparts, although 
for the wild‑type mice, the gender difference were 
much less pronounced (Yoshida et al. 2011). (Metal‑
lothionein is a metal storage protein that protects 
against the toxicities of various metals.) Similarly, in 
the earlier study, the investigators found that the brain 
concentrations of Hg were significantly higher in the 
Hg0‑exposed, metallothionein‑null female mice than in 
their male counterparts (Yoshida et al. 2005). Howev‑
er, gender differences in neurobehavioral testing were 
mixed; Hg0‑exposed metallothionein‑null male mice 
showed a significant decrease in total locomotor activ‑
ity as compared to controls, and Hg0‑exposed metallo‑
thionein‑null female mice showed a learning disability 
in the passive avoidance response and a retarded ac‑
quisition in the Morris water maze as compared with 
controls (Yoshida et al. 2005).
In conclusion, elemental mercury vapor (Hg0) was 
assigned a Rating Score of 2, showing gender‑specific 
neurotoxic effects, with the males likely being more 
affected, but not consistently so. Some recognition of 
the inconsistent and incomplete data is acknowledged.
Inorganic mercury salts
The overall neurotoxic effects of inorganic Hg salts 
do not appear to be as potent as organic alkyl Hg com‑
pounds or elemental Hg vapor. Because of, in part, the 
hydrophilic nature of inorganic Hg salts, the kidney is 
the main target organ for this form of Hg. For example, 
Khan et al. (2001) examined the uptake and distribu‑
tion of orally gavaged HgCl2 in rats. The organs exam‑
ined were: brain, gonads, heart, kidneys, liver, lungs, 
pancreas, and spleen. They found that both male and 
female rats accumulated significantly more Hg in their 
kidneys than their other organs. In regard to the gen‑
der‑selective neurotoxic effects of inorganic Hg salts, 
the evidence appears to be mixed.
For example, Zhang et al. (2013) examined HgCl2 ex‑
posure in the offspring of unsociable dams with high 
susceptibility to Hg‑induced autoimmunity (SFvF1) and 
from highly sociable dams with lower susceptibility 
to Hg‑induced autoimmunity (FvSF1). Cytokine levels 
were elevated in the brain regions of the Hg‑treated sus‑
ceptible mice but not in the lower susceptibility mice. 
Moreover, in the high susceptibility mice, the females 
had more brain regions expressing cytokines than the 
males. The social behaviors of high susceptibility mice 
were significantly impaired, with the females showing 
more of a decline in social behaviors than males. The 
greater the Hg‑induced neuroinflammation found in 
the high susceptibility female mice, the worse their so‑
ciability outcome.
In a 1997 rodent study, Pamphlett et al. also found 
greater neurotoxic effects in females from exposure to 
inorganic Hg salts. The investigators examined wheth‑
er the uptake of low‑dose HgCl2 into motor neurons dif‑
fers between male and female mice. They found that 
female mice accumulated more inorganic Hg in motor 
neuron axons than did male mice. They theorized that 
these findings might have been because the females 
accumulated less Hg in their kidneys than the males, 
leaving more circulating Hg species available to be tak‑
en up by motor neuron axons.
In a 1986 rodent study, Thomas et al. reported that 
exposure to inorganic Hg 98 days after one subcutane‑
ous dose of CH3‑Hg‑Cl in rats resulted in greater accu‑
mulation or retention of inorganic Hg in the nervous 
system in females than in males. The cumulative expo‑
sure of the brain of female rats to HgCl2 was 2.19 times 
that of the male rats.
Curtis et al. (2010) treated prairie voles with chron‑
ic ingestion of inorganic Hg salt (HgCl2) and compared 
their behavior to controls. The behavioral effects of 
HgCl2 ingestion were observed as social avoidance and 
were specific to the males. No adverse effects of inor‑
ganic Hg exposure were observed in the females.
In a rodent study, Hultman and Nielsen (2001) 
found significantly higher renal Hg concentrations and 
whole‑body Hg retention in the male mice as compared 
to those parameters in the female mice following pro‑
longed exposure to HgCl2 dissolved in drinking water.
In conclusion, inorganic mercury salts have been 
assigned a Rating Score of 3, showing gender‑specific 
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neurotoxic effects, even though it is not clear whether 
males or females are more affected. Inorganic Hg salts 
also appear to be less toxic than organic alkyl‑Hg com‑
pounds and elemental Hg0 vapor. 
Methylmercury (CH3–Hg– [i.e., Me‑Hg‑])
Several studies using animal models have shown 
greater susceptibility in males on neuropathological 
and behavioral parameters from Me–Hg exposure (pri‑
marily from Me–Hg–Cl solutions or, less often, Me–Hg–
OH solutions or Me–Hg– exposure via dietary fish [Me–
Hg–“cysteine”]). However, some earlier studies found 
that the treated females were more vulnerable than the 
like‑treated males.
Beginning with studies that show males as more 
susceptible, one example is Biamonte et al. (2014), who 
studied the interactions between three risk factors: ge‑
netic status, gender, and exposure to methylmercury, 
in heterozygous reeler (rl+/‑) mice. Mice were exposed 
to Me‑Hg during the prenatal and early postnatal peri‑
od, either at a subtoxic dose (2 ppm in Dams’ drinking 
water), or at a toxic dose (6 ppm in Dams’ drinking wa‑
ter). They reported that higher doses (predominately 
aqueous 6ppm‑Hg solutions of Me‑Hg) caused loss of 
Purkinje cells in both sexes; however, the “autism‑like” 
features (loss of sociability, preference for sameness) 
were noted only in the dosed rl+/‑ male mice.
In a study of 2‑day‑old mice receiving a single oral 
dose of 4 mg Hg/kg from Me‑Hg and sacrificed 24 hours 
or 19 days later, scientists found that the proliferating 
granule cells of the developing cerebellum underwent 
a remarkable inhibition of division, as indicated by the 
decrease in late mitotic cells. Importantly, at this low‑
er dose, there was a sex difference in sensitivity, with 
the dosed male mice being considerably more sensitive 
than the dosed females (Sager et al. 1984). Examining 
the cerebellar cortex, they found that the number of 
cells in the molecular layer and the thicknesses of the 
molecular layer and the internal granular layer were 
significantly reduced in the dosed male neonatal mice. 
All measures in females remained unaltered.
Onishchenko et al. (2007) investigated the long‑term 
effects of developmental exposure to methylmercury. 
Pregnant mice were exposed to 0.5 mg of Hg /kg/day 
from Me–Hg dissolved in their drinking water. Analysis 
of behavior exhibited in the offspring showed decreased 
exploratory activity, depression‑like behavior, and 
learning disturbances in the exposed male mice. How‑
ever, like the inorganic Hg studies discussed previously, 
the evidence indicated that Hg accumulation in the male 
offspring was greater in their kidneys than it was in the 
females’ kidneys. In the female offspring, the Hg accu‑
mulation was greater in their brain than it was in the 
males’ brain. Hirayama and Yasutake (1986) examined 
sex and age differences in Hg distribution and Hg excre‑
tion in mice given a single 5 mg/kg dose of Me–Hg–Cl. 
They found that the dosed males had lower Hg levels in 
their brain, liver, and blood than the dosed females, but 
not in their kidney tissues, which showed higher values 
than those observed for the dosed females.
Similarly, Magos et al. (1981) also found that after 
identical doses of Me‑Hg (dosed daily by gastric gavage 
four or five times with 8.0 mg/kg Hg as Me–Hg) in male 
and female rats, the brains of dosed females always 
contained more Hg than those of the identically dosed 
males. In accordance with the brain levels, the female 
rats showed greater coordination disorders and more 
extensive damage to the granular layer of the cerebel‑
lum than the male rats.
Likewise, Tagashira et al. (1980) also found that 
when mice were fed Me–Hg–Cl in food containing 50 
and 100 ppm of Me–Hg–Cl for 30 days, the females were 
more sensitive to the compound both in the onset and 
the severity of the toxic signs, particularly motor in‑
coordination. The Hg content in the brain of the dosed 
female mice tended to reach the toxicity threshold ear‑
lier than that in the brain of the males. However, when 
a single dose of Me–Hg–Cl of 50.6 mg/kg was given oral‑
ly only once, the males started to die several days soon‑
er than the females.
Inouye et al. (1986) orally fed Me–Hg–Cl to preg‑
nant mice on day 13 of pregnancy at doses of 2.5, 5, 10, 
and 20 mg/kg and examined maternal and fetal brain 
mercury levels. First, they found that the level of Hg 
was 1.6‑4.9 times higher in the fetal brain than in the 
maternal brain. They also reported that a sex differ‑
ence in Hg levels was observed in the fetal brain after 
a single Hg dose of 2.5 mg/kg was given to the pregnant 
mice. Specifically, the Hg concentration was higher in 
the females’ brain than it was in the brain of the males. 
Goulet et al. (2003) also found that chronic exposure to 
Me‑Hg‑Cl during fetal and postnatal development had 
sex‑dependent effects in mice. They found negative ef‑
fects on horizontal exploration and on working mem‑
ory in the modified T‑maze, with the treated females 
being more affected than the treated males.
In conclusion, Me‑Hg‑compounds were assigned 
a Rating Score of 3, showing gender‑specific neurotox‑
ic effects, but it is not clear whether males or females 
are more affected. 
Ethylmercury or Thimerosal [Na+ Et‑Hg‑salicylate–]
Ethylmercury (H3C‑(CH2)‑Hg‑ [Et‑Hg‑]) is the form 
of Hg present in Thimerosal (the sodium salt (Na+) 
of Et‑Hg‑“thiosalicylate”–), a compound still used as 
a preservative in many vaccines and other medical and 
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cosmetic preparations (Ni et al. 2016). Many studies 
show gender‑selective effects in the neurological sys‑
tem from exposure to Thimerosal, with males consis‑
tently found to be more vulnerable.
In the research by Branch (2009), the discovery of 
the gender‑selective effects of Thimerosal began with 
a serendipitous observation. Branch originally under‑
took a study to determine the maximum tolerated dose 
of Thimerosal in male and female CD1 mice. However, 
he found that Thimerosal has a differential maximum 
tolerated dose depending on whether the mouse was 
male or female. At doses of 38.4–76.8 mg/kg (using 10% 
aqueous DMSO as the diluent), all the male mice suc‑
cumbed to the exposure while none of the female mice 
succumbed. That study reported that Thimerosal has 
a 3‑fold increased toxicity in males compared to fe‑
males (the maximum tolerated dose of Thimerosal in 
males was 25.6 mg/kg; the maximum tolerated dose in 
females was 76.8 mg/kg).
Khan and colleagues (2012) examined cerebellar 
gene expression following perinatal Thimerosal ex‑
posure in male and female rat neonates, especially on 
thyroid‑hormone‑(TH)‑dependent gene expression and 
other genes critical for cerebellar development. They 
concluded that perinatal Thimerosal exposure results 
in altered TH‑dependent gene expression, with males 
being more sensitive to the effects of the Thimerosal 
exposure. They further stated that the genes that were 
activated by Thimerosal are negatively regulated by 
TH, supporting their hypothesis of local brain hypothy‑
roidism’s being induced by Thimerosal.
These researchers previously reported greater ef‑
fects in Thimerosal‑treated male neonates (Sulkow‑
ski et al. 2012). In that study, Sulkowski et al. (2012) 
found a greater disruption of hormones in the brain 
of male rats exposed to Thimerosal, where local in‑
tra‑brain conversion of thyroxine to the active hor‑
mone, 3’,3,5‑triiodothyronine (T3), was significantly 
decreased (60.9%) in Thimerosal‑exposed SHR male rat 
pups. However, cognitive deficits from Thimerosal ex‑
posure were found in both male and female rats. The re‑
searchers stated that the negative neurodevelopmental 
impact of perinatal Thimerosal exposure appears to be 
both strain‑ and sex‑dependent.
Olczak et al. (2011) examined neonatal treatment of 
rats with Thimerosal on behaviors, such as locomotor 
activity, anxiety, social interactions, spatial learning, 
and on the brain’s dopaminergic system. Both sex‑
es manifested impairments of locomotor activity and 
increased anxiety/neophobia in the open field test. 
When the rats were treated with the highest dose, the 
frequency of prosocial interactions was reduced, while 
the frequency of asocial/antisocial interactions was in‑
creased in males, but decreased in females. They con‑
cluded that males were more sensitive than females to 
the neurodisruptive/neurotoxic actions of Thimerosal.
In another animal study, Li et al. (2014) conducted 
a transcriptomic analysis of the neurotoxic effects af‑
ter intermittent neonatal administration of Thimerosal 
in the mouse brain. They injected mice with Thimero‑
sal at a dose 20× higher than that used for human in‑
fants during the first four months of life. Thimerosal 
exposure resulted in neural developmental delay, social 
interaction deficiency, and inclination for depression. 
Neuropathological changes were also noted in adult 
mice neonatally treated with Thimerosal. However, 
an elevation of anterior pituitary secreting hormones 
occurred exclusively in the males but not the females 
treated with Thimerosal, demonstrating the gender 
bias of the effects of Thimerosal on the pituitary‑relat‑
ed endocrine system.
Recent epidemiological studies in humans have 
found an increased risk of neurodevelopmental dis‑
orders including autism from exposure to Thimerosal 
in male infants as compared to female infants. Three 
studies, Geier et al. (2013, 2014, 2015), found, while ex‑
amining the effects of Thimerosal in the Vaccine Safety 
Datalink (VSD) and the Vaccine Adverse Reporting Sys‑
tem (VAERS), that far more males are affected by Thi‑
merosal than females. Geier et al. (2014), in particular, 
examined the dose‑response of organic mercury expo‑
sure from Thimerosal‑containing vaccines and found 
that males are at an increased risk of NDs at a lower 
exposure than females.
Studies sponsored by the US Centers for Disease 
Control (CDC) have also reported gender‑specific neu‑
rotoxicant effects from Thimerosal. Barile et al. (2012) 
and Thompson et al. (2007), for example, both report‑
ed an association between Thimerosal exposure during 
the first seven months of life and the presence of tic 
disorder in boys. 
In conclusion, Thimerosal (an Et‑Hg‑ derivative) 
was assigned a rating of 1, because numerous studies 
found consistent gender‑specific neurotoxic effects 
with males being more affected than the females.
It is important to note that epidemiological studies 
that examined gender‑specific effects of Thimerosal in 
ASD, ADHD, and tic disorder, have consistently found 
that males are more affected than females (Geier et al. 
2017). As explained by Geier et al. (2017), these disor‑
ders are abnormal brain connectivity spectrum disor‑
ders (ACSDs), which display long‑range under‑connec‑
tivity and short‑range over‑connectivity, a pathology 
in the developing brain that can result from Thimero‑
sal exposure (Kern et al. 2015). In addition, studies find 
that the symptom severity in these ASCDs correlates 
with the degree of long‑range under‑connectivity and 
short‑range over‑connectivity (Kern et al. 2015). 
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Polychlorinated biphenyls (PCBs)
Polychlorinated biphenyls (PCBs) are a group of or‑
ganochlorine compounds and a class of human‑made 
organic chemicals that have been widely used as in‑
dustrial coolants but have been banned in the US since 
1979. According to the Stockholm Convention, the rat‑
ification of the banning of organochlorine compounds 
such as PCBs worldwide occurred in 2001; however, 
in some countries, PCBs are still used for specific sit‑
uations, such as malaria vector control (Gascon et al. 
2015). Despite the ban, significant levels of PCBs are 
still present in the environment today (Gascon et al. 
2015). In a study by Gascon et al. (2015), the authors 
state that, even decades after the US (and to some ex‑
tent worldwide) ban of organochlorine compounds, 
young people in western countries today are still bioac‑
cumulating these compounds. These researchers exam‑
ined total serum burdens from birth until adolescence 
in two birth cohorts from 1997. Gascon and colleagues 
reported that despite the reduction in organochlorine 
compound concentrations, the total serum burdens of 
DDE and PCBs were higher in adolescents than at birth. 
In other words, these chemicals were continuing to ac‑
cumulate in children’s bodies.
PCBs are neurotoxicants and endocrine disrupters 
(Boas et al. 2006). Several prospective cohort studies 
have found that prenatal and early postnatal expo‑
sure to PCBs is associated with a deficit or retardation 
of mental and/or motor development (Winneke 2011). 
The pathophysiology seems to involve interference 
with thyroid metabolism during brain development 
(Winneke 2011). In regard to gender‑specific neurotox‑
icant effects, evidence suggests that, similar to Hg, the 
gender‑specific effects seem to differ depending on the 
form of PCB.
Most studies suggest that males are more affected 
the females. For example, Nguon et al. (2005) examined 
gender effects of a certain mixture of PCBs (Aroclor 
1254) on cerebellar development and motor functions 
in male and female rat neonates. They found that cer‑
ebellar mass was more reduced in male than female 
pups. Also, there was a greater increase in glial fibril‑
lary acidic protein (GFAP expression, which is indica‑
tive of neuronal damage) expression in males than in 
the females. Impaired performance on behavioral tests 
was also greater in the males.
Studying ADHD, Lombardo et al. (2015) examined 
the effects of exposure to vapor‑phase inhalation of 
PCBs (Aroclor 1248) on operant behavior of male and 
female Sprague‑Dawley rats. This exposure resulted 
in hyperactivity and impatience in the rats, and this 
was more pronounced in males than females. Similarly, 
Reilly et al. (2015) assessed the effects of gestational 
exposure to PCBs (Aroclor 1221) on the social behavior 
later in adulthood in male and female Sprague‑Dawley 
rat. Males were more sensitive than females to the tox‑
ic exposure, showing a greater decrease in several pa‑
rameters that measured sociability.
The behavioral findings that show a greater effect 
in males exposed to PCBs have also been found to paral‑
lel effects on gene expression. Bell et al. (2016), for ex‑
ample, exposed male and female Sprague‑Dawley rats 
to PCBs (Aroclor 1221) or vehicle (a substance with‑
out action) prenatally, during juvenile development, 
or both, and assessed their effects on serum hormone 
concentrations, gene expression, and DNA methylation 
in adulthood. They found that gene expression in the 
brains of males, but not females, was affected by two 
doses of the PCB solutions to which the rats were ex‑
posed, and the results observed for Aroclor 1221 solu‑
tions paralleled the negative behavioral effects of ex‑
posures to PCBs. These researchers concluded that the 
males were more vulnerable than the females to the 
treatments used.
In another study in rats, the effects of PCBs (PCB52 
and PCB180) on auditory function were examined using 
the brainstem auditory evoked potentials (Lilienthal et 
al. 2011). In that study, pregnant rats received repeat‑
ed oral doses of PCB52 and PCB180. Brainstem auditory 
evoked potentials were recorded in adult male and fe‑
male offspring. The effects were more pronounced in 
male compared with female offspring. The authors re‑
ported that latencies of waves II and IV were prolonged 
in the exposed males, whereas only wave IV was affect‑
ed in the exposed females.
Later, Lilienthal et al. (2015) also examined brain‑
stem auditory evoked potentials in adult rats exposed 
to other PCB solutions (PCB74 and PCB95). Rat dams 
were orally exposed to PCB74 or PCB95 from gestation‑
al day 10 to postnatal day 7. Control dams were given 
the vehicle (a substance without action). They found 
pronounced changes in brainstem auditory evoked 
potentials at low frequencies in PCB74 offspring, with 
elevated thresholds in both sexes. However, PCB95 in‑
creased thresholds in males, but not females.
In human infants, Berghuis et al. (2014) also found 
that prenatal exposure to PCBs (mainly 4‑OH‑PCB‑107) 
was associated with less optimal neurological function‑
ing in boys. In their observational cohort study, they 
found measurable levels of 10 PCBs and 6 OH‑PCBs in 
maternal blood samples from 98 pregnant women. 
They assessed the infants’ neurological function using 
the Touwen examination at three months and calculat‑
ed an Optimality Score. The exposures translated into 
less optimal neurological functioning in the boys.
However, some studies have found greater effects in 
females. Guo et al. (1994) studied Taiwanese children 
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born seven to twelve years after their mothers’ intoxi‑
cation by heat‑degraded PCBs. Children of the mothers 
showed a delay in development on the Chinese Child 
Developmental Inventory and on a general develop‑
ment test. Girls were more affected than boys in their 
development.
Two studies in rats showed females to be more vul‑
nerable to the neurotoxic effects for the PCBs tested. In 
a study by Chu et al. (1996a) PCB28 was investigated in 
rats after a 90‑day dietary exposure. Again, brain bio‑
genic amine changes were greater in the female rats. 
Female rats showed a decrease in dopamine concentra‑
tion in the substantia nigra region at 0.5 ppm PCB 28 and 
higher dosing. The authors concluded that the females 
were more sensitive than the males to the neurotoxic 
effects of PCB28.
In another study by Chu et al. (1996b), the authors 
examined the toxic effects of subchronic exposures 
to PCB153 in rats after 13 weeks of dietary exposure. 
PCB153 caused changes in brain biogenic amines and 
intermediate products mainly in females. The authors 
concluded that the female rats appeared to be more 
sensitive to the neurotoxic effects of low‑level expo‑
sures to PCB153 than the similarly exposed males.
However, looking at the same PCB (PCB 153) as Chu 
et al. (1996b), Dervola et al. (2015) studied gender‑de‑
pendent monoaminergic changes induced by PCB153 
in the rat brain and found changes in both the female 
and male brain with slightly more changes in the male 
brain. PCB‑exposure led to increases in monoamine 
transmitter turnover in both male and female animals. 
However, decreases in the levels of both pre‑ and post‑
synaptic dopaminergic proteins were predominantly 
seen in the male rats. 
Berghuis et al. (2015) reviewed the scientific liter‑
ature on the relationship between PCB exposure and 
childhood neurodevelopmental outcomes in studies 
from the past ten years. The authors concluded that, 
as a whole, the studies reviewed found that boys were 
more affected than girls by exposures to PCBs.
In conclusion, PCBs were assigned a Rating Score of 
2, indicating consistent gender‑specific neurotoxic ef‑
fects, with males being somewhat more affected, but 
not consistently so.
Organochlorine pesticides (e.g., dieldrin, endosulfan, 
heptachlor, dichlorodiphenyltrichloroethane [DDT], 
and dichlorodiphenyldichloroethylene [DDE])
As with PCBs (which are chlorine derivatives of the 
organic aryl compound biphenyl), the use of the or‑
ganochlorine pesticides in this section’s title were also 
“banned” (severely restricted) by/in the 1970s, and yet 
significant levels of these organochlorine pesticides 
and their breakdown products are still present in the 
environment (Caudle et al. 2005). In the study men‑
tioned earlier that addressed findings for PCBs, Gascon 
et al. (2015) reported that, in two birth cohorts from 
1997, the total serum burdens of DDE, a metabolite of 
and impurity in DDT, and PCBs were higher in the co‑
horts’ adolescents than their burdens at birth. This was 
decades after the ban in the production and use of the 
parent organochlorine pesticide, DDT, and the organo‑
chlorine‑based PCBs.
Evidence suggests that exposure to organochlorine 
pesticides and their metabolites can result in impaired 
motor and cognitive development in newborns and in‑
fants (Saeedi Saravi and Dehpour 2016), especially in 
visuomotor and sensorimotor functions (Berghuis et 
al. 2014). The nigrostriatal dopamine pathway appears 
to be one of the target systems in the brain (Wilson et 
al. 2014). Organochlorine compound exposures are also 
associated with higher rates of depression (Beard et al. 
2013). Their gender‑specific neurotoxic effects appear 
to be mixed. Two classes of these compounds, with 
slightly different toxic mechanisms, exist: DDT‑related 
insecticides and chlorinated alicyclic insecticides. The 
evidence suggests that, for the chlorinated alicyclic 
insecticides, endosulfan, dieldrin and heptachlor, the 
males were more susceptible (Wilson et al. 2014), as de‑
scribed below. However, for both DDT and DDE, females 
were more susceptible, as described below. 
Chlorinated alicyclic insecticides: endosulfan, dieldrin, and heptachlor
Wilson et al. (2014) investigated dopaminergic neu‑
rotoxicity following developmental exposure to the 
organochlorine pesticide endosulfan in offspring of 
mice fed endosulfan during gestation and lactation. 
Exposure to endosulfan during gestation and lactation 
caused a reduction in dopamine transporter and in ty‑
rosine hydroxylase (a key enzyme involved in the syn‑
thesis of dopamine, used as a marker of dopaminergic 
neurons) in the striatum of the male offspring.
Similarly, Richardson et al. (2006) examined perina‑
tal exposure of mice during gestation and lactation to 
low levels of dieldrin (an organochloride pesticide) and 
dopaminergic neurochemistry in the offspring. The 
investigators found that the exposure altered dopami‑
nergic neurochemistry and had greater adverse effects 
in the male offspring.
Later, Richardson et al. (2006) examined exposure to 
heptachlor (another organochlorine pesticide) and the 
dopamine system in an animal model. The authors stated 
that exposure of pregnant mice to heptachlor led to in‑
creased levels of both the dopamine transporter and the 
vesicular monoamine transporter 2, at both the protein 
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and mRNA level, in the offspring of the exposed preg‑
nant mice. Again, the neurotoxicity observed was great‑
er in the male offspring than in the female offspring.
This finding corroborated previous findings by Cau‑
dle et al. (2005), who also found that perinatal exposure 
of mice to the organochlorine pesticide heptachlor is 
associated with alterations of the dopamine system in 
male mice. Similar to heptachlor, Brosenitsch and Katz 
(2001) found that developmental exposure to the or‑
ganochlorine pesticide dieldrin caused increased dopa‑
mine transporter and vesicular monoamine transport‑
er 2 levels in mice, and that the observed increases in 
said transporter levels were more pronounced in the 
male offspring.
In conclusion, certain organochlorine pesticides rep‑
resented by endosulfan, dieldrin, and heptachlor were 
assigned a Rating Score of 1, showing consistent gen‑
der‑specific developmental neurotoxic effects that affect‑
ed the exposed males more than the exposed females.
It is important to note that evidence suggests that 
damage to the nigrostriatal dopamine pathway evoked 
by organochlorine insecticides leads to neurodevelop‑
mental disorders. Prospective human cohort studies 
link early‑life exposure to organochlorine pesticides 
(primarily DDT) to adverse effects on neurodevelopment 
(Roberts et al. 2012). This includes neurodevelopmen‑
tal disorders such as autism. For example, Braun et al. 
(2014) examined gestational exposure to endocrine‑dis‑
rupting chemicals and reciprocal social, repetitive, and 
stereotypic behaviors in 4‑ and 5‑year‑old children (au‑
tistic‑like behavior). They reported that exposure to 
trans‑nonachlor, a constituent of Chlordane (an organo‑
chlorine insecticide), was associated with more autis‑
tic‑like behaviors. Research also supports an association 
between low‑level prenatal organochlorine exposure 
and ADHD‑like behaviors in childhood (Sagiv et al. 2010). 
Damage to the nigrostriatal dopamine pathway from or‑
ganochlorine insecticide exposure also appears to sen‑
sitize the dopamine neurons to additional insults that 
may occur later in life and thereby increase the risk of 
Parkinson’s disease (Wilson et al. 2014). 
DDT and DDE
DDT and DDE persist in the body (DDE is a break‑
down product of DDT). The half‑life of DDT is about 
seven years, and DDE has a longer half‑life (Burns et al. 
2013). Both have been associated with behavioral prob‑
lems in childhood (Sioen et al. 2013). With regard to 
their observed gender‑specific neurotoxic effects, the 
evidence suggests that females are more affected.
In a study mentioned previously, Sioen et al. (2013) 
also assessed the association between prenatal exposure 
to DDE and subsequent behavioral problems when they 
were 7–8 years of age. Prenatal‑exposure‑associated 
neurobehavioral problems were found in girls but not 
in boys. In the prenatally exposed girls, the research‑
ers found that total neurobehavioral difficulties were 
4.92 times more likely when the cord blood level of DDE 
doubled, while no similar significant exposure‑level as‑
sociation was found in the prenatally exposed boys.
Similarly, Gaspar et al. (2015) observed that girls 
were more affected by prenatal exposure to DDT/DDE. 
These researchers measured maternal DDT/DEE con‑
centrations during pregnancy and then evaluated the 
relationship between the prenatal maternal DDT and 
DDE serum concentrations and the exposed children’s 
cognition when they were 7 and 10.5 years of age. They 
stated that the prenatal DDT levels were associated 
with delayed Processing Speed in children at 7 years 
of age and that the relationship between prenatal DDE 
levels and children’s cognitive development may be 
gender dependent, with prenatally exposed girls being 
more adversely affected.
In conclusion, certain organochlorine pesticides 
represented by DDT and DDE were assigned a Rating 
Score of 4, indicating consistent gender‑specific neuro‑
toxic effects with females being more affected than the 
similarly exposed males.
Arsenic (As)
Arsenic is a toxic mineral or metalloid sometimes 
found in water and food. Long‑term low‑level arsenic 
(As) exposure is associated with poorer neuropsycho‑
logical functioning (O’Bryant et al. 2011). Exposure to 
As is significantly related to poorer scores in language, 
visuospatial skills, executive functioning, global cogni‑
tion, processing speed, and immediate memory (O’Bry‑
ant et al. 2011). Information about gender differences 
in susceptibility to As exposures is still too limited to 
draw any definite conclusions (Llop et al. 2013).
One study in Mexican children by Rosado et al. 
(2007) found that boys exposed to As were more affect‑
ed neurologically than girls. In that study, Rosado et 
al. (2007) examined 602 children 6–8 years of age liv‑
ing within 3.5 km of a metallurgic smelter complex. 
Urinary As levels were compared to cognitive perfor‑
mance tests. They reported that several cognitive tests 
were negatively associated with urinary As levels only 
in boys. A Letter Sequencing Test also adversely affect‑
ed only boys. However, the results from a Digit Span 
subscale, which evaluated memory, were inversely cor‑
related with the girls’ urinary As levels. 
In conclusion, As was assigned a Rating Score of 5, 
because there was insufficient research related to the 
topic to draw any general gender‑based conclusions.
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Polycyclic aromatic hydrocarbons  
(e.g., naphthalene, pyrene, and florene)
Polycyclic aromatic hydrocarbons (PAHs) are 
a group of chemicals found in coal, crude oil, and gas‑
oline. PAHs are also made whenever various substanc‑
es are burned; they can be released into the air during 
the burning of fossil fuels, garbage, or other organ‑
ic substances. PAHs can persist in the environment 
for months or years. Many different PAHs exist, and 
they usually have at least one benzene ring as a part of 
their molecular structure. Examples include naphtha‑
lene, pyrene, and florene. These are present in tobacco 
smoke and are more commonly found in the air in ur‑
ban rather than in rural areas.
PAHs have neurotoxic effects (Ryan et al. 2016). 
For instance, PAHs can cause long‑lasting disruption 
in self‑regulatory capacities across early and middle 
childhood that can result in social problems (Margolis 
et al. 2013). However, in regard to gender‑specific neu‑
rotoxicant effects, the available evidence appears to be 
too limited to draw any conclusions.
In conclusion, PAHs were assigned a rating of 5, be‑
cause there is insufficient research to form any gen‑
der‑specific conclusions.
Organophosphate pesticides (e.g., chlorpyrifos, 
diazinon, malathion, parathion)
Organophosphate pesticides (OPPs) are well‑known 
neurotoxicants that have been linked to neurobehav‑
ioral deficits in children (Marks et al. 2010). In regard 
to gender‑specific neurotoxicant effects, evidence ap‑
pears to suggest that exposed males are more affected.
Marks et al. (2010), for example, investigated or‑
ganophosphate pesticide exposure in Hispanic women 
living in an agricultural region. They examined wheth‑
er organophosphate exposure, as measured by urinary 
dialkyl phosphate metabolites in pregnant women and 
their children, was associated with attention‑deficit 
outcomes among Mexican‑American children living 
in an agricultural region of California. In utero dialkyl 
phosphates and postnatal urinary dialkyl phosphates 
were adversely associated with attention as assessed 
by maternal report, psychometrician observation, and 
direct assessment. These associations were somewhat 
stronger in boys.
Aldridge et al. (2005) examined the effects of devel‑
opmental exposure to chlorpyrifos, a widely used or‑
ganophosphate pesticide, on serotonin (5HT) systems 
in the rat brain. There were alterations in factors that 
are critical to the function of the serotonin system, 
and males were more affected than females. Dam et al. 
(2000) found that, after prenatal exposure to chlorpyr‑
ifos, early postnatal deficits were observed in: a) reflex 
righting on post‑natal day 3–4 and b) geotaxic (reaction 
to gravity) responses on post‑natal day 5–8 (an effect 
that was specific to females). However, more complex 
behaviors indicated subsequent deficit selectivities in 
males. For example, open‑field locomotor activity and 
rearing were markedly reduced in male rats prenatally 
exposed to chlorpyrifos.
In conclusion, OPPs were assigned a Rating Score of 
2, gender‑specific neurotoxic effects, with males being 
somewhat more affected, but not consistently.
Endocrine disruptors including bisphenol A, other 
bisphenols (e.g., bisphenol S and bisphenol A 
diglycidyl ether), and phthalates [e.g., diiso‑nonyl 
phthalate (DINP), di(2‑ethylhexyl) phthalate 
(DEHP), dibutyl phthalate (DBP), di‑iso‑decyl 
phthalate (DIDP), di‑n‑octyl phthalate (DNOP), 
and butylbenzyl phthalate (BBP)]
Bisphenol A (BPA) and phthalates are used in mak‑
ing many plastic products in everyday commercial use, 
e.g., baby bottles, sippy cups, pacifiers, and teething 
products. Bisphenol A is used for hard, clear plastic 
products and phthalates help make plastics, like pac‑
ifiers, flexible. They both can leach from plastic into 
food, liquid, and directly into the mouths of children 
while sucking on pacifiers or teething products (West‑
chestergov.com 2016). 
Both BPA and phthalates are endocrine disruptors 
at low levels (Wise et al. 2016). Because of their wide‑
spread use, exposures are of concern. For example, 
results of recent national surveys have shown a high 
prevalence of exposure to BPA (Arbuckle et al. 2015). 
Arbuckle et al. (2015), for instance, tested urine sam‑
ples for BPA at multiple times during pregnancy in 
women and once more at 2–3 months postpartum and 
found widespread exposure among pregnant women 
and infants to environmental BPA.
Both BPA and phthalates are developmental neuro‑
toxicants that have been shown to affect the number 
of neurons in multiple brain areas in animal models 
following exposure in perinatal development, as de‑
scribed below. In regard to gender‑specific neurotoxic 
effects, the two chemicals (BPA and phthalates) appear 
to be somewhat different. 
Bisphenol A
BPA has been shown to negatively impact the de‑
velopment of estrogen‑dependent neural circuits, re‑
lated behaviors, and endocrine functions (Palanza et 
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al. 2008). Neurotoxic effects appear to include impaired 
learning, increased anxiety, and abnormal novelty re‑
sponse behaviors (Negri‑Cesi et al. 2015). BPA has been 
shown to alter the sex‑specific colonization of the hip‑
pocampus and amygdala by microglia (Rebuli et al. 
2016). However, in regard to which gender may be more 
vulnerable to the neurotoxic effects of BPA, the evi‑
dence appears to be somewhat mixed (Wise et al. 2016).
According to a review of BPA by Negri‑Cesi et al. 
(2015), which examined behaviors in prenatally ex‑
posed rodents, females seem to be more sensitive than 
males to BPA. Gioiosa et al. (2015) also conducted re‑
search on the effects of early exposure to low doses of 
BPA on behavior. Although developmental exposure to 
the estrogenic pollutant BPA had a negative impact on 
behavior in both male and female mice, the behavioral 
alterations were more pronounced in females.
Similarly, in a study by Gioiosa et al. (2015), who 
looked at the effects of early exposure to low doses of 
BPA on the subsequent behavior and metabolism in 
CD‑1 mice, the investigators found that the behavioral 
alterations were mainly in females. However, the males 
reportedly showed a significant age‑related change in 
a number of metabolic indexes.
A study by Roen et al. (2015) investigated the associa‑
tion between prenatal and early childhood BPA exposure 
and the subsequent behavioral outcomes in 7–9‑year‑old 
minority children (n=250). Both boys and girls were af‑
fected, but the direction of the associations differed be‑
tween boys and girls. High prenatal maternal urinary 
BPA concentration was associated with increased in‑
ternalizing and externalizing composite scores, which 
were consistent in the boys evaluated. Internalizing be‑
haviors reflect mood disturbance, including anxiety, de‑
pression, and social withdrawal. Externalizing behaviors 
reflect conflict with others and violation of social norms 
(Lande et al. 2009). Conversely, both negative internaliz‑
ing composite and externalizing composite scores were 
associated with high postnatal urinary BPA concentra‑
tions, which were, in turn, associated with increased 
negative behaviors in girls. The authors stated that BPA 
exposure might affect childhood behavioral outcomes in 
a sex‑specific manner and differently depending on the 
timing of exposure.
In contrast, Casas et al. (2015) examined the ef‑
fects of prenatal BPA exposure on cognitive, psycho‑
motor, and behavioral development in 438 children at 
one, four and seven years of age. They found that at 
four years of age BPA exposure was associated with an 
increased risk of ADHD‑hyperactivity symptoms and 
that this association was stronger in boys than in girls. 
However, at age seven years, the relation between BPA 
exposure and increased risk of exhibiting ADHD‑hyper‑
activity symptoms and the gender‑related differences 
in the strength of the association were not statistically 
significant.
Sobolewski et al. (2014) found that exposures to 
four endocrine disrupting chemicals, atrazine, perflu‑
orooctanoic acid, BPA, and 2,3,7,8‑tetrachlorodiben‑
zo‑p‑dioxin, caused significant adverse effects (such as 
reduced short‑term memory in the novel object recog‑
nition paradigm test) in males but not in females.
Evans et al. (2014), who examined the link between 
BPA concentration in spot urine samples from women 
at a mean of 27 weeks of pregnancy and child behavior 
assessed at age 6–10 years using the parent‑completed 
Child Behavior Checklist (CBCL), also found that BPA 
was associated with increased internalizing and ex‑
ternalizing behaviors, withdrawn/depressed behavior, 
somatic problems, and Oppositional/Defiant Disorder 
traits in boys. These authors stated that prenatal ex‑
posure to BPA might be related to increased behavior 
problems in school‑age boys but not girls.
Similarly, examining the association between pre‑
natal BPA exposure and child behavior in 198 children 
(87 boys and 111 girls), Perera et al. (2012) found that, 
among boys, high prenatal BPA exposure was associated 
with significantly higher behavioral problem scores on 
Emotionally Reactive and Aggressive Behavior syndrome 
scales. However, among girls, higher BPA exposure was 
associated with lower scores for all the behavioral syn‑
dromes tested and only reached statistical significance 
for Anxious/Depressed and Aggressive Behavior.
Studies that examine outcomes from prenatal BPA 
exposure generally find gender‑related effects. Because 
gonadal hormones are known to influence the sexual 
differentiation of the brain it is possible that exposure 
to BPA, an endocrine disrupter, could affect gonadal 
hormone levels that may contribute to sex‑specific be‑
havioral changes (Negri‑Cesi et al., 2015).
Phthalates (e.g., diiso‑nonyl phthalate [DINP], di(2‑ethylhexyl) 
phthalate [DEHP], dibutyl phthalate [DBP], di‑iso‑decyl phthalate 
[DIDP], di‑n‑octyl phthalate [DNOP], and butylbenzyl phthalate [BBP])
Comparing gender‑specific developmental neuro‑
toxic effects on a related class of endocrine disruptors, 
phthalates, the effects appear to be mixed. For exam‑
ple, Kobrosly et al. (2014) measured phthalate metabo‑
lite concentrations in urine samples from 153 pregnant 
women in the Study for Future Families, a multicenter co‑
hort study. They found that exposure to certain phthal‑
ates in late pregnancy was associated with behavioral 
problems in boys. Specifically, urinary phthalate con‑
centrations were associated with higher scores for in‑
attention, rule‑breaking behavior, aggression, conduct 
problems and somatic problems in boys. In contrast, 
girls were found to have reduced anxiety scores.
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However, in a Korean environmental health study, 
urine phthalate metabolite concentrations and neu‑
robehavioral development were examined in repre‑
sentative samples of 6–18‑year‑olds (Won et al. 2016). 
The younger children, aged 6–11 years, had significant 
positive associations between phthalate exposure and 
social problems and attention problems. Sex‑specific 
effects of phthalate exposure revealed an increase in 
thought problems among the girls.
In conclusion, endocrine disruptors (e.g., phthal‑
ates, BPA) were assigned a score of 3, with gender‑spe‑
cific neurotoxic effects, but it is unclear overall wheth‑
er males or females are more adversely affected.
Air pollution/automotive exhaust
The brain appears to be a target of air pollution 
toxicity (Allen et al. 2014a). Particles from air pollu‑
tion can enter the circulation and distribute to most 
organs, including the brain (Costa et al. 2014). Neu‑
roinflammation and oxidative stress are two putative 
biological mechanisms by which air pollutants may ad‑
versely affect the brain (Allen et al. 2014a). Evidence 
indicates that air pollution can induce neurotoxicity, 
neuroinflammation, oxidative stress, microglial acti‑
vation, cerebrovascular dysfunction, and alterations in 
the blood‑brain barrier (Davis et al. 2013, Costa et al. 
2014, Genc et al. 2012). Findings from both animal mod‑
els and human epidemiological studies show a relation‑
ship between air pollution (both traffic and industrial 
related) and neurodevelopmental disorders including 
ASD (Palmer et al. 2009, Windham et al. 2006, Volk et al. 
2013). Furthermore, these studies suggest that males 
are more vulnerable.
In an animal model, for example, Allen et al. (2014a, 
b) conducted several studies that examined the effects 
of air pollution on the brain and behavior. Mouse pups 
were exposed postnatally to concentrated ambient ul‑
trafine particles (CAPS; <100 nm) using the Harvard 
University Concentrated Ambient Particle System (HU‑
CAPS). The authors reported negative behavioral and 
cognitive impacts such as increased impulsivity and 
impaired short‑term memory, as well as structural and 
chemical brain changes. The brain changes included: 
cortical and hippocampal changes in amino acids, which 
raised the potential for excitotoxicity; and persistent 
glial activation in the frontal cortex and corpus callo‑
sum of both sexes. Both can result in brain cell (neu‑
ron) loss. They also reported evidence that suggests 
that males are more susceptible to neurotoxicity from 
air pollution (Allen et al. 2014b). CAPS induced brain 
region‑ and sex‑dependent alterations in cytokines and 
neurotransmitters in both males and females, however, 
lateral ventricle dilation (i.e., ventriculomegaly) was 
only observed in CAPS‑exposed male mice (suggesting 
brain cell/neuron loss). The authors stated that, be‑
cause ventriculomegaly is a neuropathology that has 
been associated with poor neurodevelopmental out‑
come, ASD, and schizophrenia, their findings suggest 
that alteration of developmentally important neuro‑
chemicals and lateral ventricle dilation may be mech‑
anistically involved in the link between air pollutant 
exposure and adverse neurodevelopmental outcomes 
in humans, with males being more vulnerable.
In humans, several studies find that air pollution, 
including both prenatal and postnatal exposure, is 
a risk factor for neurodevelopmental disorders, par‑
ticularly ASD. Roberts et al. (2013), for example, ex‑
amining prenatal exposure at the Harvard School of 
Public Health, estimated associations between US‑En‑
vironmental‑Protection‑Agency‑modeled levels of 
hazardous air pollutants at the time and place of birth 
and ASD in the children of participants in the Nurses’ 
Health Study II (325 cases, 22,101 controls). Their re‑
sults revealed that perinatal exposures to diesel, lead, 
manganese, mercury, methylene chloride and an over‑
all measure of metals from air pollution were signifi‑
cantly associated with ASD, with odds ratios ranging 
from 1.5 (for overall metals measure) to 2.0 (for diesel 
and mercury). They also reported that for most of the 
pollutants examined in the study, associations were 
stronger for boys (279 cases) than for girls (46 cases) 
and were significantly different according to gender 
(Roberts et al. 2013).
In conclusion, air pollution / automotive exhaust is as‑
signed a rating of 1, indicating gender‑specific neurotox‑
ic effects with males more affected (as mentioned, some 
air‑pollution studies include airborne toxic metals).
Polybrominated diphenyl ethers (brominated 
flame retardants; PBDE flame retardants)
Polybrominated diphenyl ethers (PBDEs) are orga‑
nobromine compounds, which are used as flame retar‑
dants in many products, including plastics, furniture, 
upholstery, electrical equipment, electronic devices, 
textiles, and other household products (EPA 2009). Af‑
ter several decades of commercial use, PBDEs and their 
metabolites have become pervasive environmental 
contaminants and are detectable in the human body 
(Rice et al. 2009).
Exposure to PBDEs during pregnancy can lead to 
slower mental and psychomotor development in in‑
fants (Czerska et al. 2013). Additionally, postnatal ex‑
posure has been recognized as having long‑term detri‑
mental neurotoxic effects, e.g., in spatial learning and 
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memory (Reverte et al. 2013). Berghuis et al. (2015) re‑
ported that exposure to PBDEs results in lower mental 
development, psychomotor development, and IQ, and 
poorer attention in children. In regard to gender‑spe‑
cific, neurotoxic effects, evidence suggests that males 
and females are equally affected (Viberg et al. 2004).
Rice et al. (2009), for example, examined behavior‑
al changes in aging but not young mice after neonatal 
exposure to the polybrominated flame retardant de‑
caBDE. The exposed mice learned the task more slow‑
ly, made fewer errors on the first‑response choice of 
a trial but more perseverative errors after an initial er‑
ror, and had lower latencies to respond compared with 
controls. Effects were observed on various measures 
regardless of dose and gender.
Similarly, Buratovic et al. (2014) investigated neu‑
rotoxic effects arising from neonatal exposure to PBDE 
209, including alterations in sex differences, sponta‑
neous behavior, learning, and memory. Three‑day‑old 
NMRI mice of both sexes were exposed to PBDE 209. 
They reported observing, at adult age (2–7 months), 
similar developmental neurotoxic effects in both the 
dosed male and female mice, including lack of or re‑
duced habituation to a novel home environment, as 
well as learning and memory deficits.
Likewise, Viberg et al. (2004) investigated both 
mouse strain and/or gender differences in develop‑
mental neurotoxic effects of exposure to PBDEs. They 
reported finding developmental neurotoxic effects in 
PBDE‑exposed mice. Furthermore, the developmental 
neurotoxic effects of their exposures to PBDEs were as 
pronounced in the treated female mice as they were in 
the male mice.
In conclusion, a rating Score of 6 was assigned to PB‑
DEs, indicating no gender‑specific neurotoxic effects.
Perfluorinated compounds
Certain perfluorinated compounds, e.g., perfluo‑
rooctane sulfonate (PFOS) and perfluorooctanesulfonic 
acid (PFOA), have been and are still being used in nu‑
merous industrial and consumer products. Such perflu‑
orinated compounds are now persistent environmental 
pollutants found in the tissues of fish, birds, and ma‑
rine mammals globally (Lau et al. 2004). Their tissue 
concentrations are generally higher in industrialized 
areas than in less populated locations (Suja et al. 2009). 
Exposures to these chemicals induce neurobehavioral 
effects, indicating adverse effects on the central ner‑
vous system (Lau et al. 2004, Mariussen and Fonnum 
2006). For example, in a study by Vuong et al. (2016) in 
school‑age children, maternal serum PFOS levels were 
associated with poorer behavior regulation, metacog‑
nition, and global executive functioning. The authors 
suggested that prenatal exposures to PFOS may be as‑
sociated with executive function deficits observed in 
school‑age children. However, the evidence for gen‑
der‑specific neurotoxic effects is limited.
Quaak et al. (2016) measured PFOS and PFOA in 
cord plasma using a Dutch cohort LINC (Linking Ma‑
ternal Nutrition to Child Health). The offspring in 
the cohort were followed through national registries. 
Those researchers looked for associations between the 
maternal serum concentrations and the offspring’s 
neurodevelopmental outcomes. The investigators 
found that boys in the second and third tertile (any of 
the thirds in the observed range of cord‑blood PFOA 
values arranged from low to high) of exposure to PFOA 
had significantly lower scores on the Externalizing 
Problem Scale than the boys with the lowest (first ter‑
tile) PFOA levels. The girls with elevated PFOA levels 
also had significantly lower scores on the Externaliz‑
ing Problem Scale.
In conclusion, a Rating Score of 5 was assigned to 
the class of perfluorinated compounds, because there 
is insufficient research related to the topic to draw 
any general conclusions with regard to gender‑specific 
neurotoxic effects.
Aluminum adjuvants (sparingly soluble to 
insoluble annealed polymerized inorganic 
hydroxy‑aluminum salts)
Studies report that the aluminum adjuvants used in 
vaccines bioaccumulate and persist in the brain, with 
neurological consequences such as a higher apoptotic 
index, oxidative stress, neurotoxicity, and abnormal 
cerebral perfusion in the animal model and in some 
human studies (Cabus et al. 2015, Van Der Gucht et al. 
2015, Crépeaux et al. 2015). According to Gherardi et 
al. (2015), brain translocation of aluminum particles 
is linked to a Trojan horse mechanism previously de‑
scribed for infectious particles. Once in the brain, they 
are associated with an inflammatory process (Gherardi 
et al. 2015). This current review found no studies spe‑
cifically addressing the issue of gender‑specific neuro‑
toxic effects in regard to such aluminum adjuvants. In 
conclusion, the aluminum adjuvants used in vaccines 
have been assigned a rating of 5, because we found no 
research into their gender‑specific neurotoxicity.
Glyphosate (Roundup)
Glyphosate is the active ingredient in the wide‑
ly‑used herbicide, Roundup. The US Environmental 
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Protection Agency considers glyphosate to be of rel‑
atively low oral and dermal acute toxicity (EPA 1993). 
However, in animal and tissue studies, adverse effects 
noted from glyphosate exposure include: decreased 
neuronal cell count, decreased cellular glutathione 
content, increased lipoperoxidation, excitotoxicity, 
oxidative damage, disrupted neurite development 
and maturation, and neurodegeneration (Negga et al. 
2011, Cattani et al. 2014, Coullery et al. 2016). Glypho‑
sate has been suggested to play a role in the increase 
in neurodevelopmental disorders, particularly ASD 
(Nevison 2014, Sealey at al. 2016). Nevison (2014), for 
example, presented an analysis that indicated that, 
among the neurotoxicants suspected as causal agents 
in those diagnosed with an ASD, increases in the ex‑
posure levels of PBDEs, aluminum adjuvants, and the 
herbicide glyphosate showed increasing trends that 
were positively correlated to the rise in patients diag‑
nosed with an ASD.
In this current examination, no research was found 
on gender‑specific neurotoxic effects in regard to gly‑
phosate. Thus, glyphosate was assigned a rating of 5.
RESULTS
Table III shows the results of this current exam‑
ination. The neurotoxicants that exhibited consistent 
gender‑specific effects with exposed males being more 
affected than similarly exposed females are lead, Thi‑
merosal/ethylmercury, some organochlorine pesti‑
cides (e.g., dieldrin, endosulfan, and heptachlor), and 
air pollution. These are followed by mercury vapor, 
PCBs, and organophosphate pesticides which show 
gender‑specific neurotoxic effects, with males being 
somewhat, but not consistently, more affected. The re‑
viewed neurotoxicity studies that used simple inorgan‑
ic mercury salts, methylmercury species and certain 
endocrine disruptors (e.g., phthalates and BPA) and 
found gender‑specific neurotoxic effects did not clear‑
ly establish whether the exposed males or the similarly 
exposed females were more affected.
DISCUSSION
Based on the premise that the male preponderance 
in many neurodevelopmental disorders is very possibly 
an important clue as to the etiology of these disorders, 
the evidence from this current examination suggests 
that the neurotoxicants that may play a leading role in 
the recent and dramatic increase in neurodevelopmen‑
tal disorders are: Pb, Thimerosal/ethylmercury (Et‑Hg) 
compounds, some organochlorine pesticides (e.g., diel‑
drin, endosulfan, and heptachlor), and air pollution, all 
of which showed consistent gender‑specific neurotoxic 
effects with males more affected. These are followed by 
mercury vapor, PCBs, and organophosphate pesticides, 
all of which also showed gender‑specific neurotoxic 
effects, with males being somewhat, but not consis‑
tently, more affected. Inorganic mercury salts, methyl‑
mercury‑based compounds (e.g., Me‑Hg‑Cl), and endo‑
crine disruptors (e.g., phthalates and BPA) all exhibited 
gender‑specific neurotoxic effects but did not clearly 
establish whether the exposed males or females were 
more affected.
Table III. Scoring of pollutants according to the previously described methods (see text)
Neurotoxicant Score Conclusion
Lead
Thimerosal (Na+ Et‑Hg‑thiosalicylate–) / Ethylmercury (Et‑Hg‑ )
Certain organochlorine pesticides  
(dieldrin, endosul‑fan, and heptachlor)
Air pollution 
1 Consistent gender‑specific neurotoxic effects with  males more affected
Elemental mercury vapor (Hg0)
PCBs
Organophosphate pesticides
2 Gender‑specific neurotoxic effects, with the males being somewhat more affected, but not consistently 
Inorganic mercury salts  
(Hg2+X–2, where “X” is Cl– or OH– or Hg+2Cl–2 [Calomel])
Methylmercury (Me‑Hg‑ )
Endocrine disruptors (phthalates and bisphenol A [BPA])
3 Gender‑specific neurotoxic effects, but it is not clear whether males or females are more affected
Certain organochlorine pesticides (DDT and DDE) 4 Gender‑specific neurotoxic effects, with the females being  more affected
Arsenic (As)
Polycyclic aromatic hydrocarbons (PAH)
Perfluorinated compounds
Aluminum adjuvants in vaccines & related liquid products
Glyphosate (Roundup)
5 Insufficient research related to the topic to draw any conclusions
Brominated flame retardants (PBDEs) 6 No gender‑specific neurotoxic effects
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Organochlorine pesticides (DDT and DDE) showed 
gender‑specific neurotoxic effects, but with the fe‑
males being more affected. Perfluorinated compounds, 
As, PAHs, aluminum adjuvants in vaccines & related 
liquid products, and glyphosate (Roundup) did not 
have sufficient research related to the topic to draw 
any conclusions. PBDEs showed no gender‑specific 
neurotoxic effects.
Even though there have been sociological and reg‑
ulatory changes that have significantly reduced expo‑
sure to some of these neurotoxicants, such as banning 
the use of leaded gasoline for on‑road vehicles, reduc‑
tion of the use of Thimerosal in vaccines, and reduction 
of air pollution under the Clean Air Act, there is still 
considerable room for further improvements. Many 
sources of exposure remain and many of these expo‑
sure sources could be easily reduced or eliminated. The 
following sections describe some of the current sources 
of exposure.
Lead [Pb]
Although leaded fuel is banned for use in on‑road 
vehicles in the US, aviation gasoline, or Avgas, still 
contains (Et)4Pb, which is responsible for the release of 
about 100 tons of Pb every year in the US (Bryan 2014). 
Pb is still released into the air from smelting and re‑
fining activities (U.S. Environmental Protection Agen‑
cy 2016). Other sources of Pb exposure include leaded 
crystal, dinnerware glazes, Pb water pipes and pipe 
joint solder, Pb ammunition/bullets, fishing weights, 
faucets with brass fittings, vinyl mini blinds made in 
China, some folk and Ayurvedic medicines, and some 
calcium supplements made from animal bone. Pb is still 
used in commercial products such as automotive bat‑
teries, bridge paint, computers, jewelry, and pewter.
Although banned in the European Union, Pb is pres‑
ent in 61 percent of lipsticks in the US, with levels 
ranging up to 0.65 parts per million (Campaign for Safe 
Cosmetics 2016). Similarly, Pb is banned in the use of 
hair colors in the European Union, but approved and 
used in hair colors in the US (Cosmetics Info 2016). In 
addition, many imported or pre‑regulation products 
may still pose a risk because consumer products are 
not routinely tested for Pb (Agency for Toxic Substanc‑
es and Disease Registry 2007).
Thimerosal/ethylmercury
Thimerosal is the most widely used organomercury 
compound in medicinal products (Choi et al. 2016). 
Currently, the amount of Hg present in Thimerosal‑pre‑
served vaccines nominally ranges from 12.5 to 25 mi‑
crograms per 0.5‑mL dose (with some vaccines deliv‑
ering more than 25 micrograms of Hg per dose). In the 
developing world, Thimerosal is still present in many 
of the childhood vaccines (e.g., the hepatitis B vaccines; 
the Haemophilus influenzae type b vaccines; the diphthe‑
ria, tetanus and pertussis vaccines; various inactivat‑
ed‑influenza and multi‑dose meningococcal meningitis 
vaccines). Also, the tetanus toxoid vaccine (containing 
25 micrograms of Hg per dose) and/or the inactiviated 
influenza vaccine have been recommended for admin‑
istration to pregnant women in some countries.
Other medical products that contain Thimerosal in‑
clude ear, eye and nose drops and ointments, antiseptic 
sprays, topical medications and tinctures of Merthio‑
late, antitoxins, immune globulin preparations, and 
skin‑prick test antigens (Geier et al. 2007, DermNet NZ 
2016). Thimerosal is also used in some cosmetic and 
cleansing products such as eye shadows, make‑up re‑
movers, mascaras, and soap‑free cleansers (Geier et al. 
2007, DermNet NZ 2016).
Organochlorine pesticides and PCBs
As mentioned earlier, PCB use was stopped in 1979 
when the US banned PCB manufacturing, processing, 
distribution, and use (EIP Associates 1997). For the most 
part, the use of organochlorine pesticides is barred in 
the US, although a few products are still registered for 
use. For example, exposure to lindane is possible since 
products containing this chemical are still marketed 
and used, such as in treatments for lice and scabies (Na‑
tional Institutes of Health 2016). 
Air pollution
The US EPA states that since the Clean Air Act of 
1970, air pollutants have been cut by more than 41% as 
of 2010 in the US. However, millions of children are still 
exposed to hazardous air pollutants, and in particular, 
children who live in poverty are likely to live in areas 
in which the levels of pollutants are extremely high 
(Roppolo 2014). Even under the Clear Skies Act of 2003, 
the annual “State of the Air” report stated that 47% of 
Americans live in counties with frequently unhealthy 
levels of either ozone or particulate pollution (Roppolo 
2014). There are also still many “big polluters” in the 
US (Fehling 2015), and currently there are significant 
inconsistencies in compliance from state to state with 
regard to pollution control (Fehling 2015). Industri‑
al sites, such as refineries, chlorine plants, chemical 
plants, and coal‑burning plants are among the many 
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industrial air polluters. Traffic sources have also been 
found to be associated with neurodevelopmental disor‑
ders (Palmer et al. 2009, Volk et al. 2011).
Why males might be more vulnerable
The current evidence suggests that males are more 
neurodevelopmentally vulnerable to several neurotox‑
icants than females. Research suggests that males may 
be more vulnerable for several reasons.
First, known differences in detoxification and ox‑
idative stress amelioration may explain, in part, the 
gender differences. It appears that there are signifi‑
cant gender differences in glutathione availability. Suf‑
ficient glutathione levels are critical for detoxification. 
For example, studies report an association between 
lower glutathione levels and male gender (Lavoie and 
Chessex 1997, Rush and Sandiford 2003). Lavoie and 
Chessex (1997) examined whether human tissues de‑
rived from baby girls versus baby boys had an increased 
ability to stimulate glutathione reductase when faced 
with an oxidative stress challenge. They found that, 
in vivo, the intracellular total glutathione content was 
higher in female‑derived cells. Because glutathione is 
a central element in the human antioxidant defense 
system, these results suggest that specific tissues de‑
rived from the baby girls are potentially better protect‑
ed against an oxidative stress than those derived from 
the baby boys.
Second, sulfation chemistry and sulfate availability 
differences may also partially explain the gender‑relat‑
ed differences (Kern et al. 2013). Sulfate is required for 
many physiological processes and sulfate depletion can 
both inhibit efficient detoxification and increase sus‑
ceptibility to xenobiotics. Studies in rats revealed that 
males are twice as dependent on sulfate conjugation 
for the removal of phenolic compounds as compared to 
females. In a study using acetaminophen (APAP; a phe‑
nolic compound), male rats showed a two‑fold greater 
APAP sulfotransferase activity than female rats, where‑
as the females were more dependent on glucuronide 
conjugation (Kane et al. 1990, Kern et al. 2004). In oth‑
er words, males were more dependent upon the sulfa‑
tion‑conjugation detoxification pathway than females 
and, when sulfate is depleted, the males become more 
vulnerable to intoxication by toxic substances whose 
metabolism uses that pathway. 
Third, there is also evidence that estrogen may pro‑
vide neuroprotection, whereas testosterone may en‑
hance neurotoxicity. As an example, Miller et al. (1998) 
examined striatal dopaminergic neurotoxicity induced 
by two different neurotoxicants, 1‑methyl‑4‑phe‑
nyl‑1,2,3,6‑tetrahydropyridine (MPTP) and metham‑
phetamine (METH). The authors found that both agents 
induced greater neurotoxicity in the exposed males 
than in the females as evidenced by the greater striatal 
dopamine depletions observed in males. However, when 
they observed the neurotoxicity of MPTP in ovariecto‑
mized mice, they found that it was the estrogen (not 
any metabolic/pharmacokinetic variables) that provid‑
ed the neuroprotection. Similarly, in 2008, Schaeffer 
et al. found that human neuroblastoma SH‑SY5Y cells, 
when exposed to hydrogen‑peroxide‑induced oxida‑
tive stress, were more likely to survive when they were 
pretreated with estradiol. The estradiol was protective 
against hydrogen peroxide‑induced cell death. Estra‑
diol was also capable of markedly rescuing neuroblas‑
toma cells from letrozole‑evoked cell death (letrozole 
lowers estrogen production). Haley (2005) observed 
that Thimerosal toxicity to neurons was significantly 
increased by co‑exposure with testosterone, whereas 
estrogens significantly reduced the toxicity of Thimer‑
osal to neurons.
Fourth, a greater neuroinflammatory response in 
males may also be a factor. Studies showed decreased 
neuroinflammatory responses in female mice as com‑
pared to male mice when exposed to toxicants (Fleiss et 
al. 2012). As an example, Kentner et al. (2010) examined 
the expression of the inflammatory molecule, cycloo‑
xygenase‑2 (COX‑2), after exposure to lipopolysaccha‑
ride (LPS) in rats. They found that neonatal LPS expo‑
sure at postnatal day 14 caused elevated basal expres‑
sion of hypothalamic COX‑2 in the male, but not in the 
female rats. Similarly, Smith et al. (2011) found that es‑
trogen or estrogen receptor agonists inhibited LPS‑in‑
duced microglial activation and death in the brain in 
rats. Specifically, estrogen prevented cell death by at‑
tenuating the release of interleukin‑1‑alpha, interleu‑
kin‑1‑beta, tumor necrosis factor‑α, and COX‑2. 
Several studies suggest that estrogen has protective 
effects. Estrogen modulates neural and inflammatory 
factors (Pratap et al. 2016). Findings suggest that estro‑
gens prevent and control the inflammatory response, 
shortening the pro‑inflammatory phase by facilitating 
deactivation of the inflammatory process (Villa et al. 
2016). In fact, exogenous administration of estrogen 
has been shown to improve outcomes after cerebral 
ischemia and traumatic brain injury in experimental 
models (Roof and Hall 2000).
Fifth, neurotoxic exposure can result in neuro‑
logical damage from the induction of oxidative stress 
(Risher and Tucker, 2017), and there is evidence to sug‑
gest that females are less vulnerable to oxidative stress 
(Borrás et al., 2003). Researchers report that one of the 
neuroprotective mechanisms of estrogen is linked to 
estrogen’s ability to act as an electron‑donating anti‑
oxidant (Roof and Hall, 2000). In addition, differential 
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mitochondrial oxidative stress between males and fe‑
males may also be due to mitochondria from females 
having higher levels of reduced glutathione than those 
from males and that oxidative damage to mitochondri‑
al DNA in males is 4‑fold higher than that in females 
(Borrás et al. 2003). Borrás et al. (2003) stated that fe‑
males have added protection against free‑radical‑me‑
diated damage due to higher expression and activities 
of manganese superoxide dismutase and of glutathione 
peroxidase (Borrás et al. 2003). 
Sixth, increasing evidence is demonstrating that 
progesterone (a female sex hormone) also has neuro‑
protective effects (Roof and Hall, 2000). Exogenous ad‑
ministration of progesterone, like estrogen, has been 
shown to improve outcomes after cerebral ischemia 
and traumatic brain injury in experimental models 
(Roof and Hall 2000, Stein 2011). This is the case in both 
females and males. According to Roof and Hall (2000) 
the neuroprotection from progesterone, like estrogen, 
is likely multifactorial; however, research shows that 
progesterone has a membrane stabilizing effect that 
also serves to reduce the damage caused by lipid perox‑
idation, and that it may also provide neuroprotection 
by suppressing neuronal hyperexcitability. In brain 
injury studies, Meffre et al. (2013) found modulatory 
effects of progesterone in inflammation, ion and water 
homeostasis, and myelin repair in the injured brain. 
In considering all of the aforementioned phenom‑
ena, it is important to realize that the androgen (male 
hormone) synthesis pathway and transsulfuration 
pathways directly interact with one another (Geier 
and Geier 2006, 2007, Geier et al. 2010, 2012), and as 
a consequence, may significantly potentiate neurotox‑
icant exposures, especially in developing males (Geier 
and Geier 2005). It was previously revealed that tes‑
tosterone exposure significantly down‑regulated the 
enzyme, cystathionine beta‑synthase (CBS), which 
catalyzes the committing step in the transsulfuration 
pathway, and resulted in significant decreases in intra‑
cellular glutathione and sulfate levels (Prudova et al. 
2007). Furthermore, in the androgen synthesis path‑
way, the androgen metabolite of dehydroepiandroste‑
rone (DHEA) is important to biochemically regulating 
the production of testosterone. DHEA can either be 
converted into the normally favored storage molecule 
of dehydroepiandrosterone‑sulfate (DHEA‑S), or it can 
be converted into androstenedeione or androstenediol 
in the biochemical pathway towards testosterone pro‑
duction. The enzyme hydroxysteroid sulfotransferase 
(HST) mediates the conversion of DHEA to DHEA‑S and 
it is dependent upon sulfation and glutathione and is 
inhibited by inflammation (Ryan and Carrol 1976, Kim 
et al. 2004). In addition, neurotoxicant exposures were 
revealed to significantly reduce HST function and in‑
crease androgen and testosterone levels (Ryan and Car‑
rol 1976, Freeman et al. 1977, Veltman et al. 1986, Bar‑
regard et al. 1994). The end result is that a cyclical pat‑
tern of continuous interaction between the androgen 
and transsulfuration pathways can be set into motion 
following neurotoxicant exposures that may increase 
susceptibility to neurotoxicity, particularly among de‑
veloping males (Geier and Geier 2005).
In summary, the reasons for the male brain being 
more vulnerable include: (1) greater glutathione avail‑
ability in females; (2) greater sulfate‑based detoxi‑
fication capacity in females; (3) potentiating effects 
of co‑exposure to neurotoxicants and testosterone; 
(4) greater neuroinflammatory response in males; 
(5) reduced vulnerability to oxidative stress in females; 
and (6) neuroprotective effects of female hormones 
(estrogen and progesterone), especially in the reduc‑
tion of inflammation and oxidative stress. 
Study limitations
With a few of the neurotoxicants examined in this 
study, limited research was found on their gender‑spe‑
cific neurotoxic effects. However, the lack of findings 
cannot be taken as a priori evidence of no gender‑spe‑
cific neurotoxic effects. 
In addition, the issue of gender‑specific neurotoxic 
effects with combination exposures has yet to be ad‑
equately examined. Many studies have reported syn‑
ergistic effects from the combination of toxicants. For 
example, the combination of Al and Hg as well as the 
combination of As and Pb have been shown to result 
in synergistic effects (Pohl et al. 2011, Gómez‑Oliván et 
al. 2016). As such, the issue of multiple exposures and 
how they could possibly influence gender‑specificity is 
another limitation of this current examination.
Additionally, the effects of toxic exposures are com‑
plex. The extent of the damage from exposure to toxic 
substances is dependent upon many factors, such as age 
of exposure, specific dose, exposure window, absorp‑
tion into the body, transport into the affected tissue 
(brain) or system (innate immune system), excretion, 
interaction with critical molecules versus non‑critical, 
the availability versus the depletion of detoxification 
systems, the availability of repair and compensation 
systems, stress‑response systems, cellular repair, and 
genetic susceptibility. Most of these variables were not 
considered in this study.
One of the most important parameters in toxicity is 
the specific dose (dose per unit of body weight). This 
study did not fully examine the specific‑dose variable, 
even though the evidence shows that gender‑specific 
effects can be specific‑dose‑dependent. For example, 
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Thimerosal research has shown that males are more af‑
fected than females at lower specific doses; however, 
as the specific dose becomes relatively high, the gen‑
der‑specific differences wane (Geier et al. 2014). 
A further limitation of this study is the limited dis‑
cussion of the interactions of the immune system with 
environmental factors and genetics. During develop‑
ment such interactions could very well set the stage for 
increased risk of specific neurodevelopmental and oth‑
er neurological disorders. 
CONCLUSION AND FUTURE DIRECTIONS
Over the past decade or so, several consensus pa‑
pers have been published by notable scientists on the 
relationship between neurodevelopmental disorders 
and exposures to neurotoxicants (Bennett et al. 2016; 
Grandjean and Landrigan 2006, 2014). Each consensus 
paper calls for general action in regard to exposures 
to neurotoxicants. Unfortunately, the main response 
to the dramatic increase in neurodevelopmental disor‑
ders has been a general call for early screening and in‑
tervention (Siu et al. 2016). Children are being screened 
at younger ages and programs for early interventions 
are in place in each state in the US, such as Early Child‑
hood Intervention Services and Early Childhood Pro‑
grams. Although early screening and early interven‑
tion are reported in some studies to be helpful, they are 
not preventive. Early screening and early intervention 
programs simply find and discuss the disorders early 
in hopes of reducing the severity of the symptoms ob‑
served. A true preventive program would address the 
exposure‑related issues by reducing or stopping the 
causative exposures to the identified neurotoxicants.
Not all cases of neurodevelopmental disorders are 
due to toxic exposures. However, as the consensus pa‑
pers report, the neurotoxicants examined herein are 
causal and/or contributory in many cases of neurode‑
velopmental disorders (Bennett et al. 2016). Programs 
and policies are sorely needed to reduce or eliminate 
toxic exposures. For example, the US could ban the use 
of toxic metals in makeup and cosmetics, as has been 
done in the European Union. The US could also ban the 
use of Thimerosal in the manufacture of vaccines, as has 
been done in most developed nations. The US could ban 
all use of organochlorine pesticides. It is also possible to 
dramatically reduce air pollution using current technol‑
ogy. Airborne particles can be removed from a polluted 
airstream by using currently available equipment, such 
as cyclones, scrubbers, electrostatic precipitators, and 
baghouse filters (Nathanson 2015). Wet scrubbers, for 
example, can achieve efficiencies of more than 98 per‑
cent for particles larger than 0.5 μm in diameter.
Furthermore, the cost of inaction is not only per‑
sonal but financial. For example, the Pb‑attributable 
economic costs associated with childhood Pb exposure 
in the US were estimated to be about $50.9 billion in the 
year 2011 alone (Attina and Trasande 2013). In regard to 
air pollution, Jaramillo and Muller (2016) examined air 
pollution emissions data for the years 2002, 2005, 2008, 
and 2011 to estimate monetary damages due to air pol‑
lution exposure from electric power generation, oil and 
gas extraction, coal mining, and oil refineries. Just in 
the year 2011, damages associated with emissions from 
these sectors totaled $131 billion. In a recent epidemi‑
ological study conducted by Geier et al. (2016), the in‑
vestigators estimated the cost of care of children with 
delays in development from exposure to Thimerosal in 
vaccines from 1991‑2001 to exceed $1 trillion.
The current rates of neurodevelopmental disorders 
indicate that action and true preventive legislation are 
needed. Grandjean and Landrigan (2014) stated that to 
control the pandemic of developmental neurotoxicity 
will require a global prevention strategy.
Funding availability for studies that address envi‑
ronmental factors in neurodevelopmental disorders 
should also be improved. For example, the National 
Institutes of Mental Health (NIMH) states that about 
20% of children with ASD have certain genetic con‑
ditions (National Institutes of Mental Health 2016). 
As mentioned previously, two large studies that con‑
ducted microarray examinations of the genome in ASD 
found that 80% of children diagnosed with an ASD have 
a normal genome (Shen et al. 2010, Geier et al. 2016). 
However, a search on the National Institutes of Health 
Research website using their Portfolio Online Report‑
ing (RePORT) reflects that the total budget for study‑
ing genetics in ASD in 2013 was $291 million (Research 
Portfolio Online Reporting 2016). In contrast, the total 
budget for studying environmental aspects in ASD was 
$7.5 million in 2013 (National Institute of Environmen‑
tal Health Sciences 2014). Thus, more than 38 times as 
much funding went to studying the role of genetics in 
ASD, which only addresses at best about 20% of the ASD 
population, than to studying the role of the environ‑
ment, which apparently affects at least 80% of those 
with an ASD diagnosis.
Because the exposures are numerous and are from 
multiple sources, perhaps a task force of scientists, with‑
out industry ties, who study the issue of neurodevelop‑
mental toxicity is needed. The sole mission of the task 
force would be to make recommendations to effect leg‑
islation that would address and reduce toxic exposures 
among pregnant women, infants, and children. Current 
research suggests that reducing exposures to Pb, Thi‑
merosal, organochlorine pesticides (ones that are still in 
use), and air pollution should be given priority.
1_1156_Kern_v3.indd   290 27/12/17   23:58
Neurotoxicants and male brain 291Acta Neurobiol Exp 2017, 77: 269–296
REFERENCES
Agency for Toxic Substances and Disease Registry (ATSDR), Lead Toxicity 
Where Is Lead Found? Environmental Health and Medicine Education. 
https://www.atsdr.cdc.gov/csem/csem.asp?csem=7. Page last updated: 
August 20, 2007. Accessed 23/07/2016.
Aldridge JE, Meyer A, Seidler FJ, Slotkin TA (2005) Developmental exposure 
to terbutaline and chlorpyrifos: pharmacotherapy of preterm labor and 
an environmental neurotoxicant converge on serotonergic systems in 
neonatal rat brain regions. Toxicol Appl Pharmacol 203: 132–44.
Allen JL, Liu X, Pelkowski S, Palmer B, Conrad K, Oberdörster G, Weston D, 
Mayer‑Pröschel M, Cory‑Slechta DA (2014a) Early postnatal exposure to 
ultrafine particulate matter air pollution: persistent ventriculomegaly, 
neurochemical disruption, and glial activation preferentially in male 
mice. Environ Health Perspect 122: 939–45.
Allen JL, Liu X, Weston D, Prince L, Oberdörster G, Finkelstein JN, 
Johnston CJ, Cory‑Slechta DA (2014b) Developmental exposure to con‑
centrated ambient ultrafine particulate matter air pollution in mice re‑
sults in persistent and sex‑dependent behavioral neurotoxicity and glial 
activation. Toxicol Sci 140: 160–78.
Arbuckle TE, Weiss L, Fisher M, Hauser R, Dumas P, Bérubé R, Neisa A, 
LeBlanc A, Lang C, Ayotte P, Walker M, Feeley M, Koniecki D, Tawagi G 
(2015). Maternal and infant exposure to environmental phenols 
as measured in multiple biological matrices. Sci Total Environ 508: 
575–84. 
Attina TM, Trasande L (2013) Economic costs of childhood lead exposure 
in low‑ and middle‑income countries. Environ Health Perspect 121: 
1097–102. 
Autism Speaks. New Research Finds Annual Cost of Autism Has More 
Than Tripled to $126 Billion in the U.S. and Reached £34 Billion in 
the U.K. https://www.autismspeaks.org/about‑us/press‑releases/
annual‑cost‑of‑autism‑triples. Published 03282012. Accessed 
27/01/2016. 
Barile JP, Kuperminc GP, Weintraub ES, Mink JW, Thompson WW (2012) 
Thimerosal exposure in early life and neuropsychological outcomes 
7‑10 years later. J Pediatr Psychol 37: 106‑18.
Barregard L, Lindstedt G, Schutz A, Sallsten G (1994) Endocrine function in 
mercury exposed chloralkali workers. Occup Environ Med 51: 536–40.
Beard JD, Hoppin JA, Richards M, Alavanja MC, Blair A, Sandler DP, Kamel F 
(2013) Pesticide exposure and self‑reported incident depression among 
wives in the Agricultural Health Study. Environ Res 126: 31–42. 
Bell MR, Hart BG, Gore AC (2016) Two‑hit exposure to polychlorinated bi‑
phenyls at gestational and juvenile life stages: 2. Sex‑specific neuromo‑
lecular effects in the brain. Mol Cell Endocrinol 420: 125–37. 
Bennett D, Bellinger DC, Birnaum LS et al (2016) Project TENDR: Target‑
ing Environmental Neuro‑Developmental Risks The TENDR Consensus 
Statement. Environ Health Perspect 124: A118–22.
Berghuis SA, Bos AF, Sauer PJ, Roze E (2015) Developmental neurotoxicity 
of persistent organic pollutants: an update on childhood outcome. Arch 
Toxicol 89: 687–709. 
Berghuis SA, Soechitram SD, Sauer PJ, Bos AF (2014) Prenatal exposure to 
polychlorinated biphenyls and their hydroxylated metabolites is asso‑
ciated with neurological functioning in 3‑month‑old infants. Toxicol Sci 
142: 455–62. 
Berlin M, Zalups RK, Fowler BA. Mercury. In: Nordberg GF, Fowler BA, 
Nordberg M, editors. Handbook on the toxicology of metals. 4th ed. 
Amsterdam [etc.]: Elsevier/Academic Press; 2015. p. 1013–1075.
Beyond OCD. Facts about Obsessive Compulsive Disorder. http://
beyondocd.org/ocd‑facts/. Updated 11/06/2015. Accessed 06/11/2015.
Biamonte F, Latini L, Giorgi FS, Zingariello M, Marino R, De Luca R, D’Ilio S, 
Majorani C, Petrucci F, Violante N, Senofonte O, Molinari M, Keller F 
(2014) Associations among Exposure to Methylmercury, Reduced Reelin 
Expression, and gender in the Cerebellum of Developing Mice. Neuro‑
toxicology 45: 67–80.
Boas M, Feldt‑Rasmussen U, Skakkebaek NE, Main KM (2006) Environmen‑
tal chemicals and thyroid function. Eur J Endocrinol 154: 599–611.
Bjørklund G (1995) Mercury and acrodynia. J Orthomol Med 10: 145–6.
Boyle CA, Boulet S, Schieve LA, Cohen RA, Blumberg SJ, Yeargin‑Allsopp M, 
et al (2011) Trends in the prevalence of developmental disabilities in US 
children, 1997–2008. Pediatrics 127: 1034–42.
Borrás C Sastre J,García‑Sala D, Lloret A, Pallardó FV, Viña J (2003) Mito‑
chondria from females exhibit higher antioxidant gene expression and 
lower oxidative damage than males. Free Radic Biol Med 34: 546‑52.
Branch DR (2009) Gender‑selective toxicity of thimerosal. Exp Toxicol 
Pathol 61: 133–6. 
Braun JM, Kalkbrenner AE, Just AC, Yolton K, Calafat AM, Sjödin A, Hauser R, 
Webster GM, Chen A, Lanphear BP (2014) Gestational exposure to 
endocrine‑disrupting chemicals and reciprocal social, repetitive, and 
stereotypic behaviors in 4‑ and 5‑year‑old children: the HOME study. 
Environ Health Perspect 122: 513–20.
Brosenitsch TA, Katz DM (2001) Physiological patterns of electrical stimula‑
tion can induce neuronal gene expression by activating N‑type calcium 
channels. J Neurosci 21: 2571–9.
Brubaker CJ, Dietrich KN, Lanphear BP, Cecil KM (2010). The influence of 
age of lead exposure on adult gray matter volume. Neurotoxicology 31: 
259–66.
Bryan C. US leads Avgas effort for lead‑free air. https://www.runwaygirlnetwork.
com/2014/07/30/us‑leads‑avgas‑effort‑for‑lead‑free‑air/ (Kirby Media Group). 
Published July 2014. Accessed 23/07/2016.
Bryson SE, Clark BS, Smith IM (1988) First report of a Canadian 
epidemiological study of autistic syndromes. J Child Psychol Psychiatry 
29: 433–5.
Buratovic S, Viberg H, Fredriksson A, Eriksson P (2014) Developmental 
exposure to the polybrominated diphenyl ether PBDE 209: Neurobe‑
havioural and neuroprotein analysis in adult male and female mice. En‑
viron Toxicol Pharmacol 38: 570–85. 
Burns CJ, McIntosh LJ, Mink PJ, Jurek AM, Li AA (2013) Pesticide exposure 
and neurodevelopmental outcomes: review of the epidemiologic and 
animal studies. J Toxicol Environ Health B Crit Rev 16: 127283. 
Çabuş N, Oğuz EO, Tufan AÇ, Adıgüzel E (2015) A histological study of toxic 
effects of aluminium sulfate on rat hippocampus. Biotech Histochem 
90: 132–9. 
Campbell AW (2015) Vaccines: both sides of the same coin. Alternative 
Therapies in Health and Medicine 21: 8–10. 
Campaign for Safe Cosmetics. Lead in Lipstick. http://www.safecosmetics.org/
get‑the‑facts/regulations/us‑laws/lead‑in‑lipstick/. Updated 2016. Accessed 
23/07/2016.
Casas M, Forns J, Martínez D, Avella‑García C, Valvi D, Ballesteros‑Gómez A, 
Luque N, Rubio S, Julvez J, Sunyer J, Vrijheid M (2015) Exposure to bi‑
sphenol A during pregnancy and child neuropsychological development 
in the INMA‑Sabadell cohort. Environ Res 142: 671–9. 
Cattani D, de Liz Oliveira Cavalli VL, Heinz Rieg CE, Domingues JT, Dal‑Cim T, 
Tasca CI, Mena Barreto Silva FR, Zamoner A (2014) Mechanisms under‑
lying the neurotoxicity induced by glyphosate‑based herbicide in imma‑
ture rat hippocampus: involvement of glutamate excitotoxicity. Toxicol‑
ogy 320: 34–45. 
Caudle WM, Richardson JR, Wang M, Miller GW (2005) Perinatal heptachlor 
exposure increases expression of presynaptic dopaminergic markers in 
mouse striatum. Neurotoxicology 26: 721–8.
Cecil KM, Brubaker CJ, Adler CM, Dietrich KN, Altaye M, Egelhoff JC, 
Wessel  S, Elangovan I, Jarvis K, Lanphear BP (2008) Decreased brain 
volume in adults with childhood lead exposure. PLoS Med 5: e112. 
Child Trends DataBank. ADHD, http://www.childtrends.org/wp‑content/
uploads/2012/07/76_ADHD.pdf. Updated August, 2014. Accessed 
11/17/2015.
Choi JY, Won NH, Park JD, Jang S, Eom CY, Choi Y, In Park Y, Dong MS (2016) 
Ethylmercury‑induced oxidative and endoplasmic reticulum stress‑me‑
diated autophagic cell death: involvement of autophagosome‑lysosome 
fusion arrest. Toxicol Sci 154: 27–42. 
1_1156_Kern_v3.indd   291 27/12/17   23:58
292 JK. Kern et al. Acta Neurobiol Exp 2017, 77: 269–296
Chu I, Villeneuve DC, Yagminas A, Lecavalier P, Poon R, Håkansson H, 
Ahlborg UG, Valli VE, Kennedy SW, Bergman A, Seegal RF, Feeley M 
(1996a) Toxicity of 2,4,4’‑trichlorobiphenyl in rats following 90‑day 
dietary exposure. J Toxicol Environ Health 49: 301–18.
Chu I, Villeneuve DC, Yagminas A, Lecavalier P, Poon R, Feeley M, 
Kennedy SW, Seegal RF, Håkansson H, Ahlborg UG, Valli VE, Bergman A 
(1996b) Toxicity of 2,2’,4,4’,5,5’‑hexachlorobiphenyl in rats: effects 
following 90‑day oral exposure. J Appl Toxicol 16: 121–8.
Cosmetics Info. The Science & Safety Behind Your Favorite Products. Find 
an ingredient. http://www.cosmeticsinfo.org/lead‑acetate. Updated 
2016. Accessed 23/07/2016.
Coullery RP, Ferrari ME, Rosso SB (2016) Neuronal development and axon 
growth are altered by glyphosate through a WNT non‑canonical signal‑
ing pathway. Neurotoxicology 52: 150–61. 
Crépeaux G, Eidi H, David MO, Tzavara E, Giros B, Exley C, Curmi PA, 
Shaw  CA, Gherardi RK, Cadusseau J (2015) Highly delayed systemic 
translocation of aluminum‑based adjuvant in CD1 mice following intra‑
muscular injections. J Inorg Biochem 152: 199–205. 
Cubo E (2012) Review of prevalence studies of tic disorders: methodologi‑
cal caveats. Tremor Other Hyperkinet Mov (NY) 2. 
Curtis JT, Hood AN, Chen Y, Cobb GP, Wallace DR (2010) Chronic metals in‑
gestion by prairie voles produces sex‑specific deficits in social behavior: 
an animal model of autism. Behav Brain Res 213: 42–9. 
Costa S, Ferreira J, Silveira C, Costa C, Lopes D, Relvas H, Borrego C, 
Roebeling P, Miranda AI, Teixeira JP (2014) Integrating health on 
air quality assessment‑‑review report on health risks of two major 
European outdoor air pollutants: PM and NO2. J Toxicol Environ Health 
B Crit Rev 17: 307‑40. 
C Yuen RK, Merico D, Bookman M et al (2017) Whole genome sequencing 
resource identifies 18 new candidate genes for autism spectrum disor‑
der. Nat Neurosci 20: 60211.
Czerska M, Zieliński M, Kamińska J, Ligocka D (2013) Effects of polybrominat‑
ed diphenyl ethers on thyroid hormone, neurodevelopment and fertility 
in rodents and humans. Int J Occup Med Environ Health 26: 498–510. 
Dally A (1997) The rise and fall of pink disease. Soc Hist Med 10: 291–304.
Dam K, Seidler FJ, Slotkin TA (2000) Chlorpyrifos exposure during critical neo‑
natal period elicits gender‑selective deficits in the development of coordi‑
nation skills and locomotor activity. Brain Res Dev Brain Res 121: 179–87.
Davis DA, Bortolato M, Godar SC, Sander TK, Iwata N, Pakbin P, Shih JC, 
Berhane K, McConnell R, Sioutas C, Finch CE, Morgan TE (2013) Prenatal 
exposure to urban air nanoparticles in mice causes altered neuronal 
differentiation and depression‑like responses. PLoS One 8: e64128. 
DermNetZ NZ. Thiomersal allergy. http://www.dermnetnz.org/dermatitis/
thiomersal‑allergy.html. Updated April, 2016. Accessed 25/07/2016.
Dervola KS, Johansen EB, Walaas SI, Fonnum F (2015) Gender‑dependent 
and genotype‑sensitive monoaminergic changes induced by polychlori‑
nated biphenyl 153 in the rat brain. Neurotoxicology 50: 38–45. 
EIP Associates. 1997. Polychlorinated Biphenyls (PCBs) Source Identifica‑
tion. Prepared by: EIP Associates, October 28, 1997. Prepared for: Palo 
Alto Regional Water Quality Control Plant. City of Palo Alto web page: 
http://www.cityofpaloalto.org/civicax/filebank/documents/3772. Web 
page visited: 07252016. 
EPA. 1993. “Registration Decision Fact Sheet for Glyphosate 
(EPA‑738‑F‑93‑011)” (PDF). R.E.D. FACTS. United States Environmen‑
tal Protection Agency. Accessed 04/07/2016.
EPA. 2009. “Polybrominated Diphenyl Ethers (PBDEs) Action Plan Summa‑
ry.” www.epa.gov/oppt/existingchemicals/pubs/actionpl ans/pbdes_
ap_2009_1230_final.pdf v EPA.2012. Accessed 04/07/2016.
Evens CC, Martin MD, Woods JS, Soares HL, Bernardo M, Leitäo J, et al 
(2001) Examination of dietary methylmercury exposure in the Casa Pia 
Study of the health effects of dental amalgams in children. J Toxicol En‑
viron Health Part A 64: 521–30.
Evans SF, Kobrosly RW, Barrett ES, Thurston SW, Calafat AM, Weiss B, 
Stahlhut R, Yolton K, Swan SH (2014) Prenatal bisphenol A exposure and 
maternally reported behavior in boys and girls. Neurotoxicology 45: 91–9. 
Fehling D. Houston Public Media. EPA orders Texas Coal‑burn‑
ers To Clean Up Smoke. https://www.houstonpublicmedia.org/
articles/news/2015/12/09/130514/epa‑orders‑texas‑coal‑burn‑
ers‑to‑clean‑up‑smoke/. Published 12‑9‑2015. Accessed 27/07/2016. 
Fleiss B, Nilsson MK, Blomgren K, Mallard C (2012) Neuroprotection by the 
histone deacetylase inhibitor trichostatin A in a model of lipopolysac‑
charide‑sensitised neonatal hypoxic‑ischaemic brain injury. J Neuroin‑
flammation 9: 70.
Freeman HC, Sangalang GB (1977) A study of the effects of methyl mercu‑
ry, cadmium, arsenic, selenium, and a PCB, )Aroclor 1254) on adrenal 
and testicular steroidogeneses in vitro, by the gray seal Halichoerus gry‑
pus. Arch Environ Contam Toxicol 5: 69–83
Froehlich TE, Lanphear BP, Dietrich KN, Cory‑Slechta DA, Wang N, Kahn RS 
(2007) Interactive effects of a DRD4 polymorphism, lead, and sex on ex‑
ecutive functions in children. Biol Psychiatry 62: 243–9.
Gascon M, Vrijheid M, Garí M, Fort M, Grimalt JO, Martinez D, Torrent M, 
Guxens M, Sunyer J (2015) Temporal trends in concentrations and total 
serum burdens of organochlorine compounds from birth until adoles‑
cence and the role of breastfeeding. Environ Int 74: 144–51. 
Gaspar FW, Harley KG, Kogut K, Chevrier J, Mora AM, Sjödin A, Eskenazi B 
(2015) Prenatal DDT and DDE exposure and child IQ in the CHAMACOS 
cohort. Environ Int 85: 206–12. 
Geier MR, Geier DA (2005) The potential importance of steroids in the 
treatment of autistic spectrum disorders and other disorders involving 
mercury toxicity. Med Hypotheses 64: 946–54.
Geier DA, Geier MR (2006) A clinical and laboratory evaluation of methi‑
onine cycle‑transsulfuration and androgen pathway markers in children 
with autistic disorders. Horm Res 66: 182–8.
Geier DA, Geier MR (2007) A prospective assessment of androgen levels 
in patients with autistic spectrum disorders: biochemical underpinnings 
and suggested therapies. Neuro Endocrinol Lett 28: 565–73.
Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR (2014) A dose‑re‑
sponse relationship between organic mercury exposure from thimero‑
sal‑containing vaccines and neurodevelopmental disorders. Int J Envi‑
ron Res Public Health 11: 9156–70. 
Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR (2013) 
A two‑phase cohort study of the relationship between Thimerosal‑con‑
taining vaccine administration as a risk factor for an autism spectrum 
disorder diagnosis in the United States. Translational Neurodegenera‑
tion 2: 25.
Geier DA, Kern JK, Geier MR (2010) The biological basis of autism spectrum 
disorders: understanding causation and treatment by clinical geneti‑
cists. Acta Neurobiol Exp (Wars) 70: 209–26.
Geier DA, Kern JK, Homme KG, Geier MR (2017) Abnormal brain connec‑
tivity spectrum disorders following Thimerosal administration: a pro‑
spective longitudinal case‑control assessment of medical records in the 
Vaccine Safety Datalink. Dose Response 15: 1559325817690849. 
Geier DA, Kern JK, Hooker BS, King PG, Sykes LK, Geier MR (2016) A longi‑
tudinal cohort study of the relationship between Thimerosal‑contain‑
ing hepatitis B vaccination and specific delays in development in the 
United States: Assessment of attributable risk and lifetime care costs. 
J Epidemiol Glob Health 6: 105–18.
Geier DA, Kern JK, Hooker BS, Sykes LK, Geier MR (2015) A prospective 
longitudinal assessment of medical records for diagnostic substitution 
among subjects diagnosed with a pervasive developmental disorder in 
the United States. Front Pediatr 3: 85.
Geier DA, Kern JK, King PG, Sykes LK, Geier MR (2012) An evaluation of 
the role and treatment of elevated male hormones in autism spectrum 
disorders. Acta Neurobiol Exp (Wars) 72: 1–17.
Geier DA, Kern JK, Sykes LK, Geier MR (2016a) Examining genotypic vari‑
ation in autism spectrum disorder and its relationship to parental age 
and phenotype. Appl Clin Genet 9: 121–9.
Geier DA, King PG, Hooker BS, Dórea JG, Kern JK, Sykes LK, Geier MR (2015) 
Thimerosal: clinical, epidemiologic and biochemical studies. Clin Chim 
Acta 444: 212–20. 
1_1156_Kern_v3.indd   292 27/12/17   23:58
Neurotoxicants and male brain 293Acta Neurobiol Exp 2017, 77: 269–296
Geier DA, Sykes LK, Geier MR (2007) A review of Thimerosal (Merthiolate) 
and its ethylmercury breakdown product: specific historical consider‑
ations regarding safety and effectiveness. J Toxicol Environ Health B Crit 
Rev 10: 575–96.
Genc S, Zadeoglulari Z, Fuss SH, Genc K (2012) The adverse effects of air 
pollution on the nervous system. J Toxicol 2012: 782462. 
Genuis SJ, Kelln KL (2015) Toxicant exposure and bioaccumulation: a com‑
mon and potentially reversible cause of cognitive dysfunction and de‑
mentia. Behav Neurol 2015: 620143. 
Gherardi RK, Eidi H, Crépeaux G, Authier FJ, Cadusseau J (2015) Bioper‑
sistence and brain translocation of aluminum adjuvants of vaccines. 
Front Neurol 6: 4. 
Gioiosa L, Palanza P, Parmigiani S, Vom Saal FS (2015) Risk evaluation of 
endocrine‑disrupting chemicals: effects of developmental exposure to 
low doses of Bisphenol A on behavior and physiology in mice (Mus mus‑
culus). Dose Response 13: 1559325815610760. 
Gómez‑Oliván LM, Mendoza‑Zenil YP, SanJuan‑Reyes N, Galar‑Martínez M, 
Ramírez‑Durán N, Rodríguez Martín‑Doimeadios RD, Rodríguez‑Fariñas 
N, Islas‑Flores H, Elizalde‑Velázquez A, García‑Medina S, Pérez‑Pastén 
Borja R (2016) Geno‑ and cytotoxicity induced on Cyprinus carpio by 
aluminum, iron, mercury and mixture thereof. Ecotoxicol Environ Saf 
135: 98–105. 
Goulet S, Doré FY, Mirault ME (2003) Neurobehavioral changes in mice 
chronically exposed to methylmercury during fetal and early postnatal 
development. Neurotoxicol Teratol 25: 335–47.
Grandjean P, Landrigan PJ (2006) Developmental neurotoxicity of industri‑
al chemicals. Lancet 368: 2167–78.
Grandjean P, Landrigan PJ (2014) Neurobehavioural effects of develop‑
mental toxicity. Lancet Neurol 13: 330–8.
Guo YL, Chen YC, Yu ML, Hsu CC (1994) Early development of Yu‑Cheng 
children born seven to twelve years after the Taiwan PCB outbreak. 
Chemosphere 29: 2395–404.
Haley BE (2005) Mercury toxicity: genetic susceptibility and synergistic ef‑
fects. Med Veritas 2: 535–42.
Hanna GL (1995) Demographic and clinical features of obsessive‑compul‑
sive disorder in children and adolescents. J Am Acad Child Adolesc Psy‑
chiatry 34: 19–27.
Hertz‑Picciotto I, Delwiche L (2009) The rise in autism and the role of age at 
diagnosis. Epidemiology 20: 84–90. 
Hirayama K, Yasutake A (1986) Sex and age differences in mercury dis‑
tribution and excretion in methylmercury‑administered mice. J Toxicol 
Environ Health 18: 49–60.
Homme KG, Kern JK, Geier DA, Haley BE, King PG, Sykes LK, Geier MR (2014) 
New science challenges old notion that mercury dental amalgam is safe. 
Biometals 27: 19–24. 
Hultman P, Nielsen JB (2001) The effect of dose, gender, and non‑H‑2 
genes in murine mercury‑induced autoimmunity. J Autoimmunol 17: 
27–37.
Inouye M, Kajiwara Y, Hirayama K (1986) Dose‑ and sex‑dependent alter‑
ations in mercury distribution in fetal mice following methylmercury 
exposure. J Toxicol Environ Health 19: 425–35.
Jacquemont S, Coe BP, Hersch M, Duyzend MH, Krumm N, Bergmann S, 
Beckmann JS, Rosenfeld JA, Eichler EE (2014) A higher mutational burden 
in females supports a “female protective model” in neurodevelopmen‑
tal disorders. Am J Hum Genet 94: 415–25. 
Jaramillo P, Muller NZ (2016) Air pollution emissions and damages from 
energy production in the U.S.: 2002–2011. Energy Policy 90; 202–11.
Jedrychowski W, Perera F, Jankowski J, Mrozek‑Budzyn D, Mroz E, Flak E, 
Edwards S, Skarupa A, Lisowska‑Miszczyk I (2009) Gender specific dif‑
ferences in neurodevelopmental effects of prenatal exposure to very 
low‑lead levels: the prospective cohort study in three‑year olds. Early 
Hum Dev 85: 503–10.
Joelsson P, Chudal R, Gyllenberg D, Kesti AK, Hinkka‑Yli‑Salomäki S, Virtanen 
JP, Huttunen J, Ristkari T, Parkkola K, Gissler M, Sourander A (2016) 
Demographic characteristics and psychiatric comorbidity of children 
and adolescents diagnosed with ADHD in specialized healthcare. Child 
Psychiatry Hum Dev 47: 574–82. 
Kane RE, Tector J, Brems JJ, Li AP, Kaminski DL (1990) Sulfation and glucuro‑
nidation of acetaminophen by cultured hepatocytes replicating in vivo 
metabolism. ASAIO Transactions 36: M607–610.
Kentner AC, McLeod SA, Field EF, Pittman QJ (2010) Sex‑dependent effects 
of neonatal inflammation on adult inflammatory markers and behavior. 
Endocrinology 151: 2689–99. 
Kern JK, Geier DA, King PG, Sykes LK, Mehta JA, Geier MR (2015) Shared 
brain connectivity issues, symptoms, and comorbidities in autism spec‑
trum disorder, attention deficit/hyperactivity disorder, and Tourette 
syndrome. Brain Connect 5: 321–35.
Kern JK, Haley BE, Geier DA, Sykes LK, King PG, Geier, MR (2013) Thimerosal 
exposure and the role of sulfation chemistry and thiol availability in 
autism. Int J Environ Res Public Health 10: 3771–800.
Kern JK, Waring RH, Ramsden DB, Grannemann BD, Garver CR, Trivedi MH 
(2004) Abnormal sulfation chemistry in autism. In F. Columbus 
(Ed.), Progress in Autism Research. Hauppauge, NY: Nova Science 
Publishers, Inc. 
Khanna MM (2015) Boys, not girls, are negatively affected on cognitive 
tasks by lead exposure: a pilot study. J Environ Health 77: 72–7.
Khan A, Sulkowski ZL, Chen T, Zavacki AM, Sajdel‑Sulkowska EM (2012) 
Sex‑dependent changes in cerebellar thyroid hormone‑dependent gene 
expression following perinatal exposure to thimerosal in rats. J Physiol 
Pharmacol 63: 277–83.
Khan AT, Atkinson A, Graham TC, Shireen KF (2001) Uptake and distri‑
bution of mercury in rats after repeated administration of mercuric 
chloride. J Environ Sci Health A Tox Hazard Subst Environ Eng 36: 
2039–45.
Kim MS, Shigenaga J, Moser A, Grunfeld C, Feingold KR (2004) Suppression 
of DHEA sulfotransferase Sult2A1) during the acute‑phase response. 
Am J Physiol Endocrinol Metab 28: E731‑8. 
King MD, Bearman PS (2011) Socioeconomic Status and the Increased 
Prevalence of Autism in California. Am Sociol Rev 76: 320–46.
Kishi R, Kobayashi S, Ikeno T, Araki A, Miyashita C, Itoh S, Sasaki S, 
Okada E, Kobayashi S, Kashino I, Itoh K, Nakajima S (2013) Members of 
the Hokkaido Study on Environment and Children’s Health. Ten years 
of progress in the Hokkaido birth cohort study on environment and 
children’s health: cohort profile‑updated 2013. Environ Health Prev Med 
18: 429–50.
Kobrosly RW, Evans S, Miodovnik A, Barrett ES, Thurston SW, Calafat AM, 
Swan SH (2014) Prenatal phthalate exposures and neurobehavioral de‑
velopment scores in boys and girls at 6‑10 years of age. Environ Health 
Perspect 122: 521–8. 
Kraemer S (2000) The fragile male. BMJ 321: 1609–12.
Laks, DR (2009) Assessment of chronic mercury exposure within the 
U.S. population, National Health and Nutrition Examination Survey, 
1999–2006. Biometals 22: 1103.
Lande MB, Adams H, Falkner B, Waldstein SR, Schwartz GJ, Szilagyi PG, 
Wang H, Palumbo D (2009) Parental assessments of internalizing and 
externalizing behavior and executive function in children with primary 
hypertension. J Pediatr 154: 207–12. 
Lau C, Butenhoff JL, Rogers JM (2004) The developmental toxicity of per‑
fluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198: 
231–41.
Lavoie JC. Chessex P (1997) Gender and maturation affect glutathione sta‑
tus in human neonatal tissues. Free Radical Biol Med 23: 648–57.
Liao SF, Liu JC, Hsu CL, Chang MY, Chang TM, Cheng H (2015) Cognitive 
development in children with language impairment, and correlation be‑
tween language and intelligence development in kindergarten children 
with developmental delay. J Child Neurol 30: 42–7. 
Lilienthal H, Heikkinen P, Andersson PL, van der Ven LT, Viluksela M (2011) 
Auditory effects of developmental exposure to purity‑controlled poly‑
chlorinated biphenyls (PCB52 and PCB180) in rats. Toxicol Sci 122: 
100–11. 
1_1156_Kern_v3.indd   293 27/12/17   23:58
294 JK. Kern et al. Acta Neurobiol Exp 2017, 77: 269–296
Lilienthal H, Korkalainen M, Andersson PL, Viluksela M (2015) Developmen‑
tal exposure to purity‑controlled polychlorinated biphenyl congeners 
(PCB74 and PCB95) in rats: effects on brainstem auditory evoked poten‑
tials and catalepsy. Toxicology 327: 22–31. 
Li X, Qu F, Xie W, Wang F, Liu H, Song S, Chen T, Zhang Y, Zhu S, Wang Y, 
Guo C, Tang TS (2014) Transcriptomic analyses of neurotoxic effects in 
mouse brain after intermittent neonatal administration of thimerosal. 
Toxicol Sci 139: 452–65. 
Llop S, Lopez‑Espinosa MJ, Rebagliato M, Ballester F (2013) Gender dif‑
ferences in the neurotoxicity of metals in children. Toxicology 311: 
3–12. 
Lombardo JP, Berger DF, Hunt A, Carpenter DO (2015) Inhalation of poly‑
chlorinated biphenyls (PCB) produces hyperactivity in rats. J Toxicol En‑
viron Health A 78: 1142–53. 
Magos L, Peristianis GC, Clarkson TW, Brown A, Preston S, Snowden RT 
(1981) Comparative study of the sensitivity of male and female rats to 
methylmercury. Arch Toxicol 48: 11–20.
Margolis AE, Herbstman JB, Davis KS, Thomas VK, Tang D, Wang Y, Wang S, 
Perera FP, Peterson BS, Rauh VA (2016) Longitudinal effects of prenatal 
exposure to air pollutants on self‑regulatory capacities and social com‑
petence. J Child Psychol Psychiatry 57: 851–60. 
Mariussen E, Fonnum F (2006) Neurochemical targets and behavioral 
effects of organohalogen compounds: an update. Crit Rev Toxicol 36: 
253–89.
Marks AR, Harley K, Bradman A, Kogut K, Barr DB, Johnson C, Calderon N, 
Eskenazi B (2010) Organophosphate pesticide exposure and attention 
in young Mexican‑American children: the CHAMACOS study. Environ 
Health Perspect 118: 1768–74. 
Meffre D, Labombarda F, Delespierre B, Chastre A, De Nicola AF, Stein DG, 
Schumacher M, Guennoun R (2013) Distribution of membrane proges‑
terone receptor alpha in the male mouse and rat brain and its regula‑
tion after traumatic brain injury. Neuroscience 231: 111–24. 
Miller DB, Ali SF, O’Callaghan JP, Laws SC (1998) The impact of gender and 
estrogen on striatal dopaminergic neurotoxicity. Ann N Y Acad Sci 844: 
153–65.
Nathanson JA. Encyclopaedia Britannica. Air Pollution Control. https://www.
britannica.com/technology/air‑pollution‑contro Updated 12‑13‑2015. 
Accessed 27/07/2016.
National Center for Education Statistics. The Condition of Education 2016. 
Children and Youth with Disabilities. Chapter 2. Participation in Educa‑
tion. http://nces.ed.gov/programs/coe/indicator_cgg.asp. Published in 
2016. Accessed 1/10/2016.
National Institutes of Health. US Library of Medicine. MedlinePlus. 
Lindane. https://medlineplus.gov/druginfo/meds/a682651.html. Up‑
dated 21/07/2016. Accessed 25/07/2016.
National Institute of Environmental Health Sciences. Autism and the 
Environment. http://www.niehs.nih.gov/health/materials/autism_
and_the_environment_508.pdf. Page last updated July, 2014. 
Accessed 06/09/2016. 
National Institute of Mental Health. Autism Spectrum Disorder. http://
www.nimh.nih.gov/health/topics/autism‑spectrum‑disorders‑asd/
index.shtml. Page last revised March 2016. Accessed 06/09/2016.
Negga R, Rudd DA, Davis NS, Justice AN, Hatfield HE, Valente AL, Fields AS, 
Fitsanakis VA (2011) Exposure to Mn/Zn ethylene‑bis‑dithiocarbamate 
and glyphosate pesticides leads to neurodegeneration in Caenorhabdi‑
tis elegans. Neurotoxicology 32: 331–41. 
Negri‑Cesi P (2015) Bisphenol A interaction with brain development and 
functions. Dose Response 13: 1559325815590394. 
Nevison CD (2014) A comparison of temporal trends in United States au‑
tism prevalence to trends in suspected environmental factors. Environ 
Health 13: 73. 
Nguon K, Baxter MG, Sajdel‑Sulkowska EM (2005) Perinatal exposure to 
polychlorinated biphenyls differentially affects cerebellar development 
and motor functions in male and female rat neonates. Cerebellum 4: 
112–22.
Ni J, Bi S, Xu W, Zhang C, Lu Y, Zhai L, Hu S (2016) Improved immune 
response to an attenuated pseudorabies virus vaccine by ginseng 
stem‑leaf saponins (GSLS) in combination with thimerosal (TS). Antiviral 
Res 132: 92–8. 
O’Bryant SE, Edwards M, Menon CV, Gong G, Barber R (2011) Long‑term 
low‑level arsenic exposure is associated with poorer neuropsychologi‑
cal functioning: a Project FRONTIER study. Int J Environ Res Public Health 
8: 861–74. 
Olczak M, Duszczyk M, Mierzejewski P, Meyza K, Majewska MD (2011) 
Persistent behavioral impairments and alterations of brain dopamine 
system after early postnatal administration of thimerosal in rats. Behav 
Brain Res 223: 107–18. 
Onishchenko N, Tamm C, Vahter M, Hökfelt T, Johnson JA, Johnson DA, 
Ceccatelli S (2007) Developmental exposure to methylmercury alters 
learning and induces depression‑like behavior in male mice. Toxicol Sci 
97: 428–37.
Palanza P, Gioiosa L, vom Saal FS, Parmigiani S (2008) Effects of develop‑
mental exposure to bisphenol‑A on brain and behavior in mice. Environ 
Res 108: 150–157.
Palmer RF, Blanchard S, Wood R (2009) Proximity to point sources of envi‑
ronmental mercury release as a predictor of autism prevalence. Health 
Place 15: 18–24. 
Pamphlett R, Ewan KB, McQuilty R, Waley P (1997) Gender differences in 
the uptake of inorganic mercury by motor neurons. Neurotoxicol Tera‑
tol 19: 287–93.
Perera F, Vishnevetsky J, Herbstman JB, Calafat AM, Xiong W, Rauh V, 
Wang S (2012) Prenatal bisphenol a exposure and child behavior in an 
inner‑city cohort. Environ Health Perspect 120: 1190–4. 
Pocock SJ, Ashby D, Smith MA (1987) Lead exposure and children’s intellec‑
tual performance. Int J Epidemiol 16: 57–67.
Pohl HR, Roney N, Abadin HG (2011) Metal ions affecting the neurological 
system. Met Ions Life Sci 8: 247–62.
Pratap UP, Patil A, Sharma HR, Hima L, Chockalingam R, Hariharan MM, 
Shitoot S, Priyanka HP, ThyagaRajan S (2016) Estrogen‑induced neuro‑
protective and anti‑inflammatory effects are dependent on the brain 
areas of middle‑aged female rats. Brain Res Bull 124: 238–53.
Prudova A, Albin M, Bauman Z, Lin A, Vitvitsky V, Banerjee R (2007) Tes‑
tosterone regulation of homocysteine metabolism modulates redox in 
human prostate cancer cells. Antioxid Redox Signal 9: 1875–81. 
Quaak I, de Cock M, de Boer M, Lamoree M, Leonards P, van de Bor M 
(2016) Prenatal exposure to perfluoroalkyl substances and behavioral 
development in children. Int J Environ Res Public Health 13.
Rebuli ME, Gibson P, Rhodes CL, Cushing BS, Patisaul HB (2016) Sex differ‑
ences in microglial colonization and vulnerabilities to endocrine disrup‑
tion in the social brain. Gen Comp Endocrinol 238: 39–46. 
Reilly MP, Weeks CD, Topper VY, Thompson LM, Crews D, Gore AC (2015) 
The effects of prenatal PCBs on adult social behavior in rats. Horm Be‑
hav 73: 47–55. 
Research Portfolio Online Reporting (RePORT). Search results for au‑
tism and genetics for the Fiscal Year 2013. https://projectreporter.nih.
gov/reporter_searchresults.cfm. https://projectreporter.nih.gov/
reporter_SearchResults.cfm?icde=30968654p. Page Last Updated on 
September 6, 2016. Accessed 06/09/2016.
Reverte I, Klein AB, Domingo JL, Colomina MT (2013) Long term effects of 
murine postnatal exposure to decabromodiphenyl ether (BDE‑209) on 
learning and memory are dependent upon APOE polymorphism and 
age. Neurotoxicol Teratol 40: 17–27. 
Rice DC, Thompson WD, Reeve EA, Onos KD, Assadollahzadeh M, Mar‑
kowski VP (2009) Behavioral changes in aging but not young mice after 
neonatal exposure to the polybrominated flame retardant decaBDE. 
Environ Health Perspect 117: 1903–11.
Richardson JR, Caudle WM, Wang M, Dean ED, Pennell KD, Miller GW (2006) 
Developmental exposure to the pesticide dieldrin alters the dopamine 
system and increases neurotoxicity in an animal model of Parkinson’s 
disease. FASEB J 20: 1695–7. 
1_1156_Kern_v3.indd   294 27/12/17   23:58
Neurotoxicants and male brain 295Acta Neurobiol Exp 2017, 77: 269–296
Ris MD, Dietrich KN, Succop PA, Berger OG, Bornschein RL (2004) Early ex‑
posure to lead and neuropsychological outcome in adolescence. J Int 
Neuropsychol Soc 10: 261–70.
Risher JF, Tucker P (2017) Alkyl Mercury‑induced toxicity: multiple mecha‑
nisms of action. Rev Environ Contam Toxicol 240: 105–149.
Roberts AL, Lyall K, Hart JE, Laden F, Just AC, Bobb JF, Koenen KC, Ascherio A, 
Weisskopf MG (2013) Perinatal air pollutant exposures and autism 
spectrum disorder in the children of Nurses’ Health Study II participants. 
Environ Health Perspect 121: 978–84. 
Roberts JR, Karr CJ (2012) Council on Environmental Health. Pesticide expo‑
sure in children. Pediatrics 130: e1765–88.
Robinson EB, Lichtenstein P, Anckarsäter H, Happé F, Ronald A (2013) Ex‑
amining and interpreting the female protective effect against autistic 
behavior. Proc Natl Acad Sci U S A 110: 5258–62. 
Roen EL, Wang Y, Calafat AM, Wang S, Margolis A, Herbstman J, Hoepner LA, 
Rauh V, Perera FP (2015) Bisphenol A exposure and behavioral problems 
among inner city children at 7–9 years of age. Environ Res 142: 739–45. 
Roof RL, Hall ED (2000) Gender differences in acute CNS trauma and stroke: 
neuroprotective effects of estrogen and progesterone. J Neurotrauma 
17: 367–88.
Roppolo, M. CBS NEWS. Air pollution dangerously high for almost 
half of U.S., report finds. http://www.cbsnews.com/news/
air‑pollution‑dangerously‑high‑for‑almost‑half‑of‑us/. April 30, 2014. 
Accessed 25/07/2016.
Rosado JL, Ronquillo D, Kordas K, Rojas O, Alatorre J, Lopez P, 
Garcia‑Vargas G, Del Carmen Caamaño M, Cebrián ME, Stoltzfus RJ (2007) 
Arsenic exposure and cognitive performance in Mexican schoolchildren. 
Environ Health Perspect 115: 1371–5.
Rush JW, Sandiford SD (2003) Plasma glutathione peroxidase in healthy 
young adults: Influence of gender and physical activity. Clinical Bio‑
chemistry 36: 345–51.
Ryan RA, Carrol J (1976) Studies on a 3beta‑hydroxysteroid sulphotransfer‑
ase from rat liver. Biochim Biophys Acta 429: 391–401.
Ryan KR, Sirenko O, Parham F, Hsieh JH, Cromwell EF, Tice RR, Behl M 
(2016) Neurite outgrowth in human induced pluripotent stem cell‑de‑
rived neurons as a high‑throughput screen for developmental neuro‑
toxicity or neurotoxicity. Neurotoxicology 53: 271–81. 
Saeedi Saravi SS, Dehpour AR (2016) Potential role of organochlorine pes‑
ticides in the pathogenesis of neurodevelopmental, neurodegenerative, 
and neurobehavioral disorders: A review. Life Sci 145: 255–64. 
Sager PR, Aschner M, Rodier PM (1984) Persistent, differential alterations 
in developing cerebellar cortex of male and female mice after methyl‑
mercury exposure. Brain Res 314: 1–11.
Sagiv SK, Thurston SW, Bellinger DC, Tolbert PE, Altshul LM, Korrick SA 
(2010) Prenatal organochlorine exposure and behaviors associated with 
attention deficit hyperactivity disorder in school‑aged children. Am J Ep‑
idemiol 171: 593–601. 
Schaafsma SM, Pfaff DW (2014) Etiologies underlying sex differences in Au‑
tism Spectrum Disorders. Front Neuroendocrinol 35: 255–71. 
Schaeffer V, Patte‑Mensah C, Eckert A, Mensah‑Nyagan AG (2008) Selective 
regulation of neurosteroid biosynthesis in human neuroblastoma cells 
under hydrogen peroxide‑induced oxidative stress condition. Neurosci‑
ence 151: 758–70. 
Schettler T (2001) Toxic threats to neurologic development of children. En‑
viron Health Perspect 109: 813–816. 
Schendel DE, Grønborg TK, Parner ET (2014) The genetic and environmen‑
tal contributions to autism: looking beyond twins. JAMA 311: 1738–9. 
Sealey LA, Hughes BW, Sriskanda AN, Guest JR, Gibson AD, 
Johnson‑Williams L, Pace DG, Bagasra O (2016) Environmental factors in 
the development of autism spectrum disorders. Environ Int 88: 288–98. 
Shen Y, Dies KA, Holm IA, et al (2010) Autism Consortium Clinical Genetics/
DNA Diagnostics Collaboration. Clinical genetic testing for patients with 
autism spectrum disorders. Pediatrics 125: e727–35.
Sioen I, Den Hond E, Nelen V, Van de Mieroop E, Croes K, Van Larebeke N, 
Nawrot TS, Schoeters G (2013) Prenatal exposure to environmental con‑
taminants and behavioural problems at age 7–8 years. Environ Int 59: 
225–31. 
Siu AL; US Preventive Services Task Force (USPSTF), Bibbins‑Domingo K, 
Grossman DC, Baumann LC, Davidson KW, Ebell M, García FA, Gillman M, 
Herzstein J, Kemper AR, Krist AH, Kurth AE, Owens DK, Phillips WR, 
Phipps MG, Pignone MP (2016) Screening for autism spectrum disorder 
in young children: US Preventive Services Task Force Recommendation 
Statement. JAMA. 315: 691–6.
Smith JA, Das A, Butler JT, Ray SK, Banik NL (2011) Estrogen or estrogen re‑
ceptor agonist inhibits lipopolysaccharide induced microglial activation 
and death. Neurochem Res 36: 1587–93. 
Sobolewski M, Conrad K, Allen JL, Weston H, Martin K, Lawrence BP, 
Cory‑Slechta DA (2014) Sex‑specific enhanced behavioral toxicity induced 
by maternal exposure to a mixture of low dose endocrine‑disrupting 
chemicals. Neurotoxicology 45: 121–30. 
Stein DG (2011) Progesterone in the treatment of acute traumatic brain 
injury: a clinical perspective and update. Neuroscience 191: 101–6. 
Stessman HA, Xiong B, Coe BP, et al (2017) Targeted sequencing identifies 
91 neurodevelopmental‑disorder risk genes with autism and develop‑
mental‑disability biases. Nat Genet 49: 515–26.
Stewart PW, Delbagno V, Ng J, Burright R, Donovick P (1998) Subacute Pb 
exposure during development and unbaited tunnel maze performance 
in mice. Pharmacol Biochem Behav 59: 183–9.
Sugiyama T, Abe T. (1989) The prevalence of autism in Nagoya, Japan: 
a total population study. J Autism Dev Disord 19: 87–96.
Suja F, Pramanik BK, Zain SM (2009) Contamination, bioaccumulation and 
toxic effects of perfluorinated chemicals (PFCs) in the water environ‑
ment: a review paper. Water Sci Technol 60: 1533–44. 
Sulkowski ZL, Chen T, Midha S, Zavacki AM, Sajdel‑Sulkowska EM (2012) 
Maternal thimerosal exposure results in aberrant cerebellar oxidative 
stress, thyroid hormone metabolism, and motor behavior in rat pups; 
sex‑ and strain‑dependent effects. Cerebellum 11: 575‑86. 
Tagashira E, Urano T, Yanaura S (1980) [Methylmercury toxicosis. I. Rela‑
tionship between the onset of motor incoordination and mercury con‑
tents in the brain (author’s transl)]. Nihon Yakurigaku Zasshi 76: 169‑77.
Thomas DJ, Fisher HL, Sumler MR, Marcus AH, Mushak P, Hall LL (1986) 
Sexual differences in the distribution and retention of organic and inor‑
ganic mercury in methyl mercury‑treated rats. Environ Res 41: 219–34.
Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, 
Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, 
Stewart G, Weintraub ES, Davis RL, DeStefano F; Vaccine Safety Datalink 
Team (2007) Early thimerosal exposure and neuropsychological out‑
comes at 7 to 10 years. N Engl J Med 357: 1281–92.
U.S. Department of Education. OSEP’s Annual Reports to Congress on the 
Implementation of the Individuals with Disabilities Education Act (IDEA). 
http://www2.ed.gov/about/reports/annual/osep/index.html. Modified 
01/08/2016. Accessed 08/15/2016.
U.S. Department of Education (1980) Second annual report to Congress on 
the implementation of Public Law 94–142: The Education for All Handi‑
capped Children Act. Washington, DC: Author. 
U.S. Environmental Protection Agency. Lead. Protect Your Family from Ex‑
posures to Lead. https://www.epa.gov/lead/protect‑your‑family‑expo‑
sures‑lead. Updated April 21, 2016. Accessed 23/07/2016.
Van Der Gucht A, Aoun Sebaiti M, Itti E, Aouizerate J, Evangelista E, Chalaye J, 
Gherardi RK, Ragunathan‑Thangarajah N, Bachoud‑Levi AC, Authier FJ 
(2015) Neuropsychological correlates of brain perfusion SPECT in 
patients with macrophagic myofasciitis. PLoS One 10: e0128353.
Veltman JC, Maines MD (1986) Alterations of heme, cytochrome P‑450, and 
steroid metabolism by mercury in rat adrenal. Arch Biochem Biophys 
248: 467–78.
Viberg H, Fredriksson A, Eriksson P (2004) Investigations of strain and/or 
gender differences in developmental neurotoxic effects of polybromi‑
nated diphenyl ethers in mice. Toxicol Sci 81: 344–53. 
Villa A, Vegeto E, Poletti A, Maggi A (2016) Estrogens, neuroinflammation 
and neurodegeneration. Endocr Rev 37: 372–402. 
1_1156_Kern_v3.indd   295 27/12/17   23:58
296 JK. Kern et al. Acta Neurobiol Exp 2017, 77: 269–296
Volk HE, Hertz‑Picciotto I, Delwiche L, Lurmann F, McConnell R (2011) Resi‑
dential proximity to freeways and autism in the CHARGE study. Environ 
Health Perspect 119: 873–7. 
Volk HE, Lurmann F, Penfold B, Hertz‑Picciotto I, McConnell R (2013) Traf‑
fic‑related air pollution, particulate matter, and autism. JAMA Psychiatry 
70: 71–7. 
Vuong AM, Yolton K, Webster GM, Sjödin A, Calafat AM, Braun JM, 
Dietrich  KN, Lanphear BP, Chen A (2016) Prenatal polybrominated 
diphenyl ether and perfluoroalkyl substance exposures and executive 
function in school‑age children. Environ Res 47: 556–64. 
Wagner M, Kutash K, Duchnowski AJ, Epstein MH, Sumi WC (2005) The 
children and youth we serve: A national picture of the characteristics 
of students with emotional disturbances receiving special education. 
J Emotional Behav Disord 13: 79–96.
Westchestergov.com. BIsphenol‑A (BPA). http://health.westchestergov.
com/bisphenol‑a‑and‑phthalates Westchestergov.com. copyright 2016 
Westchester County. Accessed 22/06/3013.
Wilson WW, Shapiro LP, Bradner JM, Caudle WM (2014) Developmental expo‑
sure to the organochlorine insecticide endosulfan damages the nigrostria‑
tal dopamine system in male offspring. Neurotoxicology 44: 279‑87. 
Windham GC, Zhang L, Gunier R, Croen LA, Grether JK (2006) Autism spec‑
trum disorders in relation to distribution of hazardous air pollutants 
in the San Francisco bay area. Environ Health Perspect 114: 1438–44.
Winneke G (2011) Developmental aspects of environmental neurotoxicology: 
lessons from lead and polychlorinated biphenyls. J Neurol Sci 308: 9–15. 
Winneke G, Lilienthal H, Krämer U (1996) The neurobehavioural toxicology 
and teratology of lead. Arch Toxicol Suppl 18: 57–70.
Wise LM, Sadowski RN, Kim T, Willing J, Juraska JM (2016) Long‑term effects 
of adolescent exposure to Bisphenol A on neuron and glia number in 
the rat prefrontal cortex: Differences between the sexes and cell type. 
Neurotoxicology 53: 186–192.
Won EK, Kim Y, Ha M, Burm E, Kim YS, Lim H, Jung DE, Lim S, Kim SY, 
Kim YM, Kim HC, Lee KJ, Cheong HK, Kang HT, Son M,Sakong J, Oh GJ, 
Lee CG, Kim SY, Ryu JM, Kim SJ (2016) Association of current phthalate 
exposure with neurobehavioral development in a national sample. Int 
J Hyg Environ Health 219: 364–71. 
Woods JS, Heyer NJ, Russo JE, Martin MD, Farin FM (2014) Genetic poly‑
morphisms affecting susceptibility to mercury neurotoxicity in children: 
summary findings from the Casa Pia Children’s Amalgam clinical trial. 
Neurotoxicology 44: 288–302.
Woods JS, Martin MD, Leroux BG, et al (2007) The contribution of dental 
amalgam to urinary mercury excretion in children. Environ Health Per‑
spect 115: 1527–31.
Yoshida M, Honda M, Watanabe C, Satoh M, Yasutake A (2011) Neuro‑
behavioral changes and alteration of gene expression in the brains 
of metallothionein‑I/II null mice exposed to low levels of mercury 
vapor during postnatal development. J Toxicol Sci 36: 539–47.
Yoshida M, Watanabe C, Horie K, Satoh M, Sawada M, Shimada A (2005) 
Neurobehavioral changes in metallothionein‑null mice prenatally ex‑
posed to mercury vapor. Toxicol Lett 155: 361–8.
Zablotsky B, Black LI, Maenner MJ, Schieve LA, Blumberg SJ. Estimated 
Prevalence of Autism and Other Developmental Disabilities Following 
Questionnaire Changes in the 2014 National Health Interview Survey. 
National Health Statistics Reports. Volume 87. http://www.cdc.gov/nchs/
data/nhsr/nhsr087.pdf. Published 11/13/2015. Accessed 13/11/2015.
Zhang Y, Bolivar VJ, Lawrence DA (2013) Maternal exposure to mercury 
chloride during pregnancy and lactation affects the immunity and social 
behavior of offspring. Toxicol Sci 133: 101–11.
1_1156_Kern_v3.indd   296 27/12/17   23:58
